TW201139358A - Clathrate and method for producing same - Google Patents
Clathrate and method for producing same Download PDFInfo
- Publication number
- TW201139358A TW201139358A TW100101845A TW100101845A TW201139358A TW 201139358 A TW201139358 A TW 201139358A TW 100101845 A TW100101845 A TW 100101845A TW 100101845 A TW100101845 A TW 100101845A TW 201139358 A TW201139358 A TW 201139358A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- acid
- group
- composition
- inclusion compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/4007—Curing agents not provided for by the groups C08G59/42 - C08G59/66
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/4007—Curing agents not provided for by the groups C08G59/42 - C08G59/66
- C08G59/4014—Nitrogen containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/42—Polycarboxylic acids; Anhydrides, halides or low molecular weight esters thereof
- C08G59/4223—Polycarboxylic acids; Anhydrides, halides or low molecular weight esters thereof aromatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/50—Amines
- C08G59/5046—Amines heterocyclic
- C08G59/5053—Amines heterocyclic containing only nitrogen as a heteroatom
- C08G59/5073—Amines heterocyclic containing only nitrogen as a heteroatom having two nitrogen atoms in the ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Epoxy Resins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
201139358 六、發明說明: 【發明所屬之技術領域】 本發明係關於一種新穎之包接化合物及其製造方法 、 其是關於一種可用作環氧樹脂硬化觸媒等之包含芳香族幾 酸化合物及咪嗤化合物的包接化合物及其製造方法與含有 包接化合物之環氧樹脂組合物或其硬化物。 本申請案係針對2010年1月20曰提出申請之曰本專利申 請第2010-10375號、2010年10月8曰提出申請之日本專利 申請第2010-228645號主張優先權,並引用其内容至本文 中。 【先前技術】 環氧樹脂由於具有優異之機械特性、熱特性,故而廣泛 用於各種領域。作為用於使該環氧樹脂硬化之硬化劑,目 則係使用咪唑系化合物,但環氧樹脂_咪唑系化合物之混 合液存在硬化之起始較早,單液穩定性極差之問題。 因此,對於硬化劑,現提出有使用於咪唑系化合物中添 加羥基苯甲酸之鹽(參照專利文獻”,或使用四苯酚系化合 物(例如1,1,2,2-四(4-羥基苯基)乙烷(以下稱為TEp乃與咪唑 系化合物之包接體(參照專利文獻2)。所述咪唑酸加成鹽或 包接體雖然可發揮一定效果,但仍期待開發出具有與其同 等之機能者或機能進一步提昇者。 因此業界k出並開發出一種含有下述式(i)所表示之間 本二曱酸化合物與下述式(ii)所表示之咪唑化合物的包接 化合物(專利文獻3), 153278.doc 201139358 [化l]BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel inclusion compound and a method for producing the same, which relates to an aromatic acid-containing compound which can be used as an epoxy resin hardening catalyst and the like. The inclusion compound of the oxime compound and the method for producing the same, and the epoxy resin composition containing the inclusion compound or a cured product thereof. The present application claims priority from Japanese Patent Application No. 2010-228645, filed on Jan. 20, 2010, filed on Jan. In this article. [Prior Art] Epoxy resins are widely used in various fields because of their excellent mechanical properties and thermal properties. As the curing agent for curing the epoxy resin, an imidazole-based compound is used, but the mixture of the epoxy resin and the imidazole-based compound has a problem that the curing starts earlier and the stability of the single liquid is extremely poor. Therefore, for the hardener, a salt to which a hydroxybenzoic acid is added to an imidazole-based compound has been proposed (refer to the patent literature), or a tetraphenol-based compound (for example, 1,1,2,2-tetrakis (4-hydroxyphenyl) is used. Ethane (hereinafter referred to as TEp is an inclusion body of an imidazole-based compound (see Patent Document 2). Although the imidazolium acid addition salt or the inclusion body exhibits a certain effect, it is expected to develop the same. The functional person or function is further improved. Therefore, the industry has developed and developed an inclusion compound containing the present dicarboxylic acid compound represented by the following formula (i) and the imidazole compound represented by the following formula (ii) (patent Literature 3), 153278.doc 201139358 [Chemical]
COOHCOOH
[式中,Ri表示C1-C6烷基、C1~C6烷氧基、硝基或羥基] [化2][wherein, Ri represents a C1-C6 alkyl group, a C1 to C6 alkoxy group, a nitro group or a hydroxyl group] [Chemical 2]
[式中,R2表示氫原子、C1〜C10烷基、芳基、芳基烷基或 氰基乙基’ R3〜Rs分別獨立表示氫原子、硝基、鹵素原 子、可具有取代基之C1~C20烧基、經經基取代之C1〜C20 烧基、芳基、芳基烷基或C1〜C20之醯基]。 專利文獻3中之包接化合物之製法如下:將間苯二甲酸 化合物與咪唾化合物添加至溶劑中之後,視需要一邊進行 搜拌’ 一邊進行加熱處理或加熱回流處理,而使之析出。 又’该文獻記載有:若考慮到於溶劑中之易溶解性,則較 佳為將式⑴所表示之間苯二甲酸化合物及式(ii)所表示之 咪唑化合物分別溶解於溶劑中之後,再將溶解液彼此混 然而’專利文獻3中並未具體地記載5_羥基間苯二甲酸 與2-苯基-4-甲基-5-羥基甲基咪唑之包接化合物,並且若 153278.doc •4· ⑧ 201139358 藉由該專利文獻中所記載之方法使5_羥基間笨二甲酸與2_ 苯基-4-甲基-5-羥基甲基咪唑進行反應,則僅獲得兩化合 物之1 : 1包接化合物與1 : 2包接化合物之混合物。 此外,雖然已可以高純度製造5_羥基間苯二甲酸與2_苯 基-4-甲基-5-羥基甲基咪唑之丨:丨包接化合物(專利文獻 4),但未能以高純度製造1 : 2包接化合物。 先前技術文獻 專利文獻 專利文獻1:曰本專利特公平4-2638號公報 專利文獻2:曰本專利特開平11_71449號公報 專利文獻3:國際公開2008/075427號手冊 專利文獻4 :國際公開2009/037862號手冊 【發明内容】 發明所欲解決之問題 因此’本發明之課題在於以高純度獲得5_羥基間苯二曱 酸等芳香族羧酸化合物與2-苯基-4-曱基-5-羥基甲基咪唑 等咪唑類之1 : 2包接化合物。 解決問題之技術手段 本發明者等人經過努力研究,結果發現:藉由反覆改良 5-羥基間苯二甲酸與2-笨基-4-甲基-5-羥基曱基咪唑之混合 方法’可獲得主體與客體之莫耳比為1 : 2之包接化合物 (以下簡稱為1 : 2包接化合物)。進一步反覆研究,結果判 明:藉由針對已知主體與客體之莫耳比僅為1 : 1之包接化 合物(以下簡稱為1 : 1包接化合物)的包接化合物之主體化 153278.doc 201139358 合物與客體化合物,利用本申請發明之製造法,可製造 1 : 2包接化合物。又,對藉由公知之製造法可製造^ 接化合物者與無法製造進行比較,結果判明:於作為主: 化合物之芳香族羧酸化合物於溶劑中之溶解性較差之情J 時,藉由公知方法無法製造i ·· 2包接化合物。同時,=現 可製造含有此1:2包接化合物之硬化性環氧樹脂組合物及 其硬化物’並且發現其特性與含有i : i包接化合物之情形 相比有所提昇’從而完成本發明。 即’本發明係關於如下内容: (1)-種包接化合物或其組合物’其含有包含芳香顧酸化 合物(A)及下述式(11)所表示之化合物印)且(a)與⑺)之莫耳 比為1 : 2之包接化合物,並且該包接化合物於含有(⑷與 (B)之全部包接化合物中占70莫耳0/〇〜1〇〇莫耳%, 、 [化3]Wherein R 2 represents a hydrogen atom, a C1 to C10 alkyl group, an aryl group, an arylalkyl group or a cyanoethyl group; R3 to Rs each independently represent a hydrogen atom, a nitro group, a halogen atom, and a C1 which may have a substituent; C20 alkyl, C1-C20 alkyl, aryl, arylalkyl or C1 to C20 thiol group substituted by a radical. The inclusion compound in the patent document 3 is produced by adding an isophthalic acid compound and a sodium salic compound to a solvent, and then performing a heat treatment or a heat reflow treatment while precipitating it as needed. In addition, it is preferable to dissolve the phthalic acid compound represented by the formula (1) and the imidazole compound represented by the formula (ii) in a solvent, respectively, in consideration of the solubility in a solvent. Further, the solutions are mixed with each other. However, Patent Document 3 does not specifically describe the inclusion compound of 5-hydroxyisophthalic acid and 2-phenyl-4-methyl-5-hydroxymethylimidazole, and if 153278. Doc •4· 8 201139358 By reacting 5-hydroxyl-p-dicarboxylic acid with 2-phenyl-4-methyl-5-hydroxymethylimidazole by the method described in the patent document, only one of the two compounds is obtained. : 1 a mixture of a compound and a 1:2 inclusion compound. Further, although it has been possible to produce a ruthenium-containing compound of 5-hydroxyisophthalic acid and 2-phenyl-4-methyl-5-hydroxymethylimidazole in high purity (Patent Document 4), it has not been high. Purity manufacturing 1: 2 inclusion compound. CITATION LIST Patent Literature Patent Literature 1: Patent Publication No. 4-2638 Patent Document 2: Japanese Patent Laid-Open No. Hei 11-71449, Patent Document 3: International Publication No. 2008/075427, Patent Document 4: International Publication 2009/ SUMMARY OF THE INVENTION PROBLEM TO BE SOLVED BY THE INVENTION Therefore, the object of the present invention is to obtain an aromatic carboxylic acid compound such as 5-hydroxyisophthalic acid and 2-phenyl-4-mercapto-5 in high purity. - 1 : 2 inclusion compound of imidazoles such as hydroxymethylimidazole. Means for Solving the Problems The inventors of the present invention have diligently studied and found that by repeatedly improving the mixing method of 5-hydroxyisophthalic acid and 2-phenyl-4-methyl-5-hydroxydecyl imidazole An inclusion compound having a molar ratio of 1 to 2 (hereinafter referred to as a 1:2 inclusion compound) is obtained. Further research was carried out, and it was found that the hostation of the inclusion compound by the inclusion compound (hereinafter referred to as 1:1 inclusion compound) with a molar ratio of only 1:1 to the known host and guest 153278.doc 201139358 The compound and the guest compound can be produced into a 1:2 inclusion compound by the production method of the present invention. Further, when a compound which can be produced by a known production method can be produced and compared with the case where it is impossible to manufacture, it is found that the solubility of the aromatic carboxylic acid compound as a main compound in a solvent is poor, and it is known. The method cannot produce i ·· 2 inclusion compounds. At the same time, it is now possible to manufacture a curable epoxy resin composition containing the 1:2 inclusion compound and its hardened material 'and found that its characteristics are improved compared with the case of containing i : i inclusion compound' invention. That is, the present invention relates to the following: (1) an inclusion compound or a composition thereof containing a compound comprising a aromatic acid compound (A) and a compound represented by the following formula (11); and (a) (7)) The inclusion ratio of the molar ratio of 1:2, and the inclusion compound accounts for 70 mol/0% of the total inclusion compound of (4) and (B), [Chemical 3]
(式中’ R2表示氫原子' C1〜C10烧基、芳基、芳基燒基或 氰基乙基’ r3〜r5表示氫原子、硝基、_素原子、 院基、經經基取代之C1〜C20院基、芳基、芳基烷基或 C1〜C20之酿基,帶虛線之部分表示單鍵或雙鍵). (2)如上述(1)之包接化合物或其組合物,其中芳香族羧酸 化合物為下述式(III)或下述式(IV)所表示之化合物, 153278.doc _6_ ⑧ 201139358(wherein R 2 represents a hydrogen atom 'C1 to C10 alkyl, aryl, arylalkyl or cyanoethyl' r3 to r5 represent a hydrogen atom, a nitro group, a sulfonium atom, a nominee group, a trans-substituted group C1 to C20, aryl, arylalkyl or C1 to C20, the dotted line represents a single bond or a double bond. (2) The inclusion compound or the composition thereof according to (1) above, Wherein the aromatic carboxylic acid compound is a compound represented by the following formula (III) or the following formula (IV), 153278.doc _6_ 8 201139358
(COOH)n1 (ΙΠ) [化4] (^6)η2 (式中,nl表示1~4中之任一整數;n2表示0〜4中之任一整 數;R6表示C1〜C6烷基、硝基或羥基) [化5] (^7)m2 -(COOH)ml (17) (式中’ ml表示1〜4中之任一整數;表示〇〜2中之任一整 數;R7表示C1〜C6烷基、硝基、羥基或下式所表示之基, [化 6] ^(COOH)n1 (ΙΠ) [Chemical 4] (^6) η2 (wherein nl represents any integer from 1 to 4; n2 represents any integer from 0 to 4; and R6 represents a C1 to C6 alkyl group, Nitro or hydroxy) [Chem. 5] (^7) m2 - (COOH) ml (17) (wherein 'ml denotes any integer from 1 to 4; denotes any integer from 〇~2; R7 denotes C1 ~C6 alkyl, nitro, hydroxy or the group represented by the following formula, [Chemical 6] ^
(COOH)q r二心μ q表或2之整數;*表示鍵結位置)); (3)如上述" 下述式(I) L接化合物或其組合物,其中上述式(IV)為 [化7](COOH) qr dicentric μ q table or an integer of 2; * represents a bonding position)); (3) a compound of the following formula (I), or a combination thereof, wherein the above formula (IV) is [Chemistry 7]
153278.doc 201139358153278.doc 201139358
(式中,Ri表示Cl〜C6烷基、C1〜C6烷氧基、硝基 基); I ()上述(3)之包接化合物或其組合物,其中上述式( 5-羥基間苯二曱酸;及 一 (5) 如上述⑴至(4)中任—項之包接化合物或其組合物,其 中上述式(II)為2_苯基甲基_5_經基甲基味„坐。 又,本發明係關於如下内容: (6) —種如上述(1)之包接化合物或其組合物之製造方法, 其係向上述式(II)之化合物之醇液中添加芳香族羧酸化人 物; 。 (7) —種如上述(1)之包接化合物或其組合物之製造方法, 其係向上述式(II)之化合物中添加芳香族羧酸化合物之醇 溶液;進而, (8) —種硬化性環氧樹脂組合物或其硬化物,其含有如上述 (1)至(5)中任一項之包接化合物或其組合物、與環氧樹 脂。 【實施方式】 (包接化合物或其組合物) 本發明之包接化合物或其組合物係將芳香族羧酸化合物 (以下簡稱為「羧酸化合物」)作為主體化合物,將下述式 (II)所表示之咪唑化合物或咪唑啉化合物(以下簡稱為咪。坐 化合物)作為客體化合物,且羧酸化合物與啼唑化合物之 莫耳比僅為1 : 2之包接化合物’或以高純度含有莫耳比為 1 : 2之包接化合物的組合物, 153278.doc ⑧ 201139358 [化8] R4 Rs Η (Π) 丫、r2 r3 (式中’ r2表示氫原子、C1〜C職基、芳基、芳基烧基或 氛基乙基’ r3〜r5表示氫原子、硝基、齒素原子、ci〜c2〇 院基、經經基取代之C1〜C20烧基、芳基、芳基烷基或 C1〜C20之醯基;帶虛線之部分表示單鍵或雙鍵卜 羧酸化合物與咪唑化合物之莫耳比為1 : 2之包接化合物 中有時會混入1: i等不同莫耳比之包接化合物,於本發明 中將其稱為上述包接化合物之組合物。 關於本發明之包接化合物或其組合物,於含有羧酸化合 物與咪唑化合物之全部包接化合物中,丨:2包接化合物之 含有比例為7〇莫耳%以上,較佳為8〇莫耳%以上,更佳為 90莫耳。/。以上,更佳為實質上不混有i :】等其他莫耳比之 包接化合物。纟中,本發明之包接化合物亦可含有溶劑等 第成刀β亥第3成分較佳為40莫耳%以下,更佳為1〇莫耳 %以下,最佳為不含第3成分之包接化合物。本發明中所 謂包接化合物’係指主體化合物形成包接晶格,且主體化 合物以共價鍵以外之鍵與!種或2種以上之客體化合物鍵結 而成之化。物’更佳為結晶性化合物。含有缓酸化合物及 ㈣化合物之本發明之包接化合物亦可稱為由㈣化合物 與°米°坐化合物所形成之鹽。 153278.doc 201139358 作為簡稱’ 5-經基間苯二甲酸稱為「mpA」,2_苯基冰 甲基-5-羥基甲基咪唑稱為「2p4MHz」。 此處所謂包接晶格,係指如下者:主體化合物彼此以共 價鍵以外之鍵進行鍵結,於經鍵結之主體化合物之2分子 或3分子以上之間隙中,利用共價鍵以外之鍵包接有其他 分子(客體或溶劑等)、或其他分子及主體化合物者;或主 體化合物與其他分子(客體或溶劑等)以共價鍵以外之鍵相 鍵結,於與其他分子鍵結之主體化合物之2分子或3分子以 上之間隙中’利用共價鍵以外之鍵包接有主體化合物及/ 或其他分子(客體或溶劑等)者。 本發明之包接化合物可用作聚酯樹脂、環氧樹脂、環 氧-聚醋樹脂等樹脂之硬化劑,尤其適合用作環氧樹脂之 硬化劑。树明t環氧樹脂組合物可適宜地用於使環氧樹 脂硬化之用途,例如環氧樹脂系接著劑、半導體密封材 料、液晶用密封材料、印刷配線用積層板、清漆、⑽材 料、油墨等用途。χ ’本發明之包接化合物雖然可為溶解 於溶劑中之液狀者,但較佳為(於溶劑中析出之)粉體狀 者。藉由使其成為粉體狀,例如可用於粉體塗料。 包接化合物之結構可藉由熱分析(TG及DTA)、紅外吸收 光譜(IR)、X線繞射(XRD)圖案、固態NMR光譜等而確 認。又,包接化合物之組成可藉由熱分析、!h_Nmr光 譜、高效液相層析法(HPLC)、元素分析等而確認。 又,1 : 2包接化合物之含有比例(純度)於例如為包含 1 : 1包接化合物與1 : 2包接化合物之組合物之情形時,可 153278.doc ,10. 201139358 根據純度(%)=〗:2包接化合物/(1 : i包接化合物+ι : 2包 接化合物)x100,由包接化合物之lH_NMR之積分值算出。 作為一例,HIPA與2P4MHZ之丨:2包接化合物之純度可使 用於刪⑽6中、饥下之啊之積分值除以ppm 之積分值而得的值(a),根據下式求得。 1 . 2包接化合物之純度(%)=(2a/n>xi〇〇 (羧酸化合物) 作為芳香族羧酸化合物,並無特別限制,例如可例示以 下者。 苯曱酸、2-甲基苯甲酸、3-曱基苯甲酸、4·甲基苯甲 酸、2-乙基笨甲酸、3-乙基苯甲酸、4·乙基苯甲酸、2-正 丙基苯甲酸、3-正丙基苯曱酸、4-正丙基苯甲酸、2-丁基 苯曱酸、3-丁基苯曱酸、4-丁基苯甲酸、2_異丙基苯曱 酸、3 -異丙基苯甲酸、4-異丙基苯曱酸、2_異丁基苯曱 酸、3 -異丁基苯曱酸、4-異丁基苯甲酸、2-經基苯甲酸、 3-羥基苯甲酸、4-羥基苯甲酸、2-硝基笨甲酸、3-硝基苯 曱酸、4-硝基苯曱酸、2-硝基笨甲酸曱酯、3_硝基苯曱酸 甲酯、4-硝基苯曱酸甲酯、2-硝基笨甲酸乙酯、3-硝基苯 曱酸乙醋、4-硝基苯甲酸乙ί旨、2-硝基苯曱酸丙S旨、3-石肖 基笨甲酸丙酯、4-石肖基苯曱酸丙酯、2-石肖基苯甲酸丁酯、 3-硝基苯甲酸丁酯、4-硝基苯曱酸丁酯、2,3_二甲基苯曱 酸、2,4-二曱基笨曱酸' 2,5-二曱基苯曱酸、2,6-二曱基苯 甲酸、3,4-二甲基苯曱酸、3,5-二甲基苯曱酸、3,6-二甲基 笨甲酸、4,5-二曱基苯曱酸、4,6-二甲基苯甲酸、2,3-二乙 153278.doc 201139358 基苯甲酸、2,4-二乙基苯曱酸、2,5-二乙基苯曱酸、2,6-二 乙基苯甲酸、3,4-二乙基苯甲酸、3,5-二乙基苯甲酸、3,6-二乙基苯曱酸、4,5-二乙基苯甲酸、4,6-二乙基苯甲酸、 2,3-二羥基苯曱酸、2,4-二羥基苯甲酸、2,5-二羥基笨曱 酸、2,6-二羥基苯甲酸、3,4-二羥基苯甲酸、3,5-二羥基苯 曱酸、3,6-二羥基苯曱酸、4,5-二羥基笨曱酸、4,6-二羥基 苯曱酸; 鄰苯二曱酸、3-甲基鄰苯二甲酸、4-曱基鄰苯二甲酸、 5- 甲基鄰苯二甲酸、6-甲基鄰苯二甲酸、3-乙基鄰苯二曱 酸、4-乙基鄰苯二甲酸、5-乙基鄰苯二曱酸、6-乙基鄰苯 二甲酸、3-正丙基鄰苯二曱酸、4-正丙基鄰苯二甲酸、5· 正丙基鄰苯二甲酸、6-正丙基鄰苯二曱酸、3 -丁基鄰苯二 曱酸、4-丁基鄰苯二甲酸、5-丁基鄰苯二甲酸、6_丁基鄰 苯二甲酸、3-異丙基鄰苯二甲酸、4-異丙基鄰苯二甲酸、 5 -異丙基鄰苯二甲酸、6 -異丙基鄰苯二甲酸、異丁基鄰 苯二甲酸、4-異丁基鄰苯二甲酸、5_異丁基鄰苯二曱酸、 6- 異丁基鄰苯二甲酸、3-羥基鄰苯二甲酸、4_超基鄰笨二 甲酸、5-羥基鄰苯二甲酸、6-羥基鄰苯二曱酸、3,4_二羥 基鄰苯二甲酸、3,5-二羥基鄰苯二甲酸、3,6_二羥基鄰苯 二甲酸、4,5-二羥基鄰苯二曱酸、4,6_二羥基鄰苯二甲 酸、3-硝基鄰苯二甲酸、4-硝基鄰苯二甲酸、5_硝基鄰苯 二曱酸、6-硝基鄰苯二曱酸、3,4·二甲基鄰苯二甲酸、3,5_ 二曱基鄰苯二甲酸、3,6_二甲基鄰苯二甲酸、4,5_二甲基 鄰苯二甲酸、4,6-二曱基鄰苯二甲酸; 153278.doc 12 • · ⑧ 201139358 間苯二甲酸、2-甲基間苯二甲酸、4_甲基間苯二曱酸、 5-甲基間苯二甲酸、6-曱基間苯二曱酸、2_乙基間苯二曱 酸、4-乙基間苯二甲酸、5-乙基間笨二甲酸、6-乙基間苯 二甲酸、2-正丙基間苯二甲酸、4-正丙基間苯二曱酸、5_ 正丙基間苯二甲酸、6-正丙基間苯二曱酸、2_異丙基間苯 二甲酸、4·異丙基間苯二曱酸、5_異丙基間苯二曱酸、6_ 異丙基間苯二甲酸、2- 丁基間苯二甲酸、4_ 丁基間苯二甲 酸、5-丁基間笨二曱酸、6·丁基間苯二曱酸、入異丁基間 苯二曱酸、4-異丁基間苯二曱酸、5_異丁基間苯二曱酸、 6-異丁基間笨二曱酸、4-第三丁基間苯二曱酸、5_第三丁 基間苯二曱酸、6_第三丁基間苯二甲酸、2_羥基間苯二甲 酸、4-羥基間苯二甲酸、5_羥基間苯二甲酸、6_羥基間笨 二甲酸、2’4-二羥基間苯二曱酸、2,5_二羥基間苯二甲 酸、2,6-二羥基間苯二甲酸、4,5•二羥基間苯二甲酸、4,6_ 二羥基間苯二甲酸、5,6_二羥基間笨二甲酸、2,4·二甲基 間苯二甲冑、2,5_二甲基間苯二甲酸、2,6_二曱基間苯二 甲I 4,5-—甲基間苯二曱酸、4,6_二曱基間笨二甲酸、 5’6_-甲基間苯二甲酸、2•硝基間苯二甲冑、确基間笨 二甲酸、5-硝基間苯二甲酸、“肖基間笨二甲酸、2_甲基 對苯二甲豸、2.乙基對苯二甲酸、2_正丙基對苯二甲酸、 異丙基對苯二甲酸、2_ 丁基對苯二甲酸、2•異丁基對笨 :甲酸、2-經基對笨二甲酸、2,6_二經基對笨二甲酸、a :甲基對苯二甲冑、2-硝基對苯二甲酸、1,2,3-苯三羧 a夂1,2’4-本二鲮酸(偏笨三酸)、苯三羧酸、υ,4·笨 153278.doc 13· 201139358 二叛酸、 装 ,,本二綾酸、3-羥基-1,2,4-苯三羧酸、5- 二叛酸、6·經基-1,2,4-苯三羧酸、12,4,5-苯 四羧酸(均苯四酸); 、甲酸2_萘曱酸、2_甲基-1-萘甲酸、3-甲基-1-萘甲 :、4-甲基-1-萘甲酸、”基」·萘甲酸、"基小萘甲 :、7·曱基_1_萘曱酸、8_甲基q•萘甲酸、卜甲基冬萘甲 甲基-2_萘曱酸、4-曱基_2-萘甲酸、5_甲基_2_萘曱 馱、6'甲基·2·萘甲酸、7_甲基_2•萘甲酸、8_甲基_2_萘甲 酸、1’2-萘二羧酸、丨,3_萘二羧酸、Μ_萘二羧酸、ι,5_萘 二羧酸、1,6-萘二羧酸、〗,7_萘二羧酸、丨,8_萘二羧酸、 2’3·萘二羧酸、2,4-萘二羧酸、2,5_萘二羧酸、2,6_萘二羧 酸、2,7_萘二羧酸、2,8-萘二羧酸、2-羥基_ι·萘甲酸、3_ 羥基-1-萘曱酸、4-羥基-1-萘甲酸、5_羥基萘曱酸、心 經基-1-萘甲酸、7-羥基-1-萘曱酸、8-羥基-1·萘曱酸、卜 經基-2-萘甲酸、3-經基-2-萘甲酸、4-經基·2-萘曱酸、5_ 經基-2-萘曱酸、6-經基-2 -萘甲酸、7-經基-2-萘甲酸、8_ 羥基-2-萘甲酸、1,2,4,5-萘四羧酸、2,3-二羥基萘甲 酸、2,4-二羥基-1-萘甲酸、2,5-二羥基-1-萘甲酸、2,6_二 經基-1-萘甲酸、2,7-二經基-1-萘甲酸、2,8-二經基_ι_萘曱 酸、3,4-二羥基-1·萘甲酸、3,5_二羥基-1-萘甲酸、3,6-二 經基-1-蔡甲酸、3,7-二經基-1-萘甲酸、3,8-二經基_1_萘曱 酸、4,5-二經基-卜奈甲酸、4,6 -二經基-1-萘甲酸' 4,7_二 經基-1-萘甲酸、4,8-二經基-1-萘甲酸、5,6-二經基-i_萘曱 153278.doc -14- 201139358 酉文、5,7·二羥基-1·萘甲酸、5,8-二羥基-1-萘甲酸、6,7-二 羥基_1~萘甲酸、6,8-二羥基_ι_萘曱酸、7,8-二羥基-1_萘 甲酸、匕3-二羥基·2-萘甲酸、1,4-二羥基-2-萘甲酸、1,5- 一羥基萘甲酸、1,6-二羥基-2-萘甲酸、1,7-二羥基-2-萘 甲酸、1,8-二羥基·2_萘曱酸、3,4_二羥基_2_萘甲酸、3,5· 一羥基-2-萘尹酸、3,6_二羥基_2_萘甲酸、3,8_二羥基_2•萘 甲酿、4 < 二羥基_2_萘甲酸、4,6_二羥基_2_萘甲酸、4,7_ 一羥基-2-萘甲酸、4,8_二羥基_2_萘甲酸、5,6_二羥基_2_萘 甲酸、5,7-二羥基-2-萘曱酸、5,8-二羥基-2-萘甲酸、6,7-一羥基-2-萘甲酸、6,8_二羥基_2萘曱酸、7,8二羥基_2_ 蔡甲酸、環己羧酸、丨,2•環己二羧酸、丨,3_環己二羧酸、 已二幾酸、丨,1·環己二羧酸、1,2-十氫萘二羧酸、 l3-十氫萘二羧酸、〗,4_十氫萘二羧酸、1,5-十氫萘二羧 ,十氫萘二羧酸、1,7-十氫萘二鲮酸、丨,8_十氫萘二 羧酸等。 亦可併用2種以 該等芳香族羧酸化合物可單獨使用1種 上0 該等中’較佳為下述式㈣或下述 族竣酸化合物, 所表示之芳香 [化9] (R6)n2(wherein, Ri represents a Cl~C6 alkyl group, a C1 to C6 alkoxy group, a nitro group); I () an inclusion compound of the above (3) or a composition thereof, wherein the above formula (5-hydroxyisophthalene) The inclusion compound of any one of the above-mentioned items (1) to (4), or a composition thereof, wherein the above formula (II) is a 2-phenylmethyl-5-yl-methyl group Further, the present invention relates to the following: (6) A method for producing an inclusion compound according to the above (1) or a composition thereof, which comprises adding an aromatic group to an alcohol liquid of the compound of the above formula (II) (7) The method for producing an inclusion compound according to the above (1) or a composition thereof, which comprises adding an alcohol solution of an aromatic carboxylic acid compound to the compound of the above formula (II); (8) A curable epoxy resin composition or a cured product thereof, comprising the inclusion compound according to any one of the above (1) to (5), or a composition thereof, and an epoxy resin. (Inclusion compound or composition thereof) The inclusion compound of the present invention or a composition thereof is an aromatic carboxylic acid compound (hereinafter referred to as "carboxylic acid compound" As the host compound, an imidazole compound or an imidazoline compound represented by the following formula (II) (hereinafter abbreviated as a sodium compound) is used as a guest compound, and the molar ratio of the carboxylic acid compound to the carbazole compound is only 1 : 2 encapsulated compound' or a composition containing a molar ratio of 1:2 inclusive compound, 153278.doc 8 201139358 [Chemical 8] R4 Rs Η (Π) 丫, r2 r3 (in the formula R2 represents a hydrogen atom, a C1~C-based group, an aryl group, an arylalkyl group or an arylethyl group 'r3~r5" represents a hydrogen atom, a nitro group, a dentate atom, a ci~c2 fluorene group, and is substituted by a thiol group. a C1-C20 alkyl group, an aryl group, an arylalkyl group or a C1 to C20 fluorenyl group; a dotted line representing a single bond or a double bond carboxylic acid compound and an imidazole compound having a molar ratio of 1:2 The inclusion compound of different molar ratios such as 1: i may be mixed in the present invention, and is referred to as a composition of the above-mentioned inclusion compound in the present invention. The inclusion compound of the present invention or a composition thereof contains a carboxylic acid. In the total inclusion compound of the compound and the imidazole compound, 丨: 2 inclusion compound The content ratio is 7 〇 mol% or more, preferably 8 〇 mol% or more, more preferably 90 mol%. More preferably, it is substantially not mixed with i :] and other other molar ratios In the compound, the inclusion compound of the present invention may contain a solvent such as a solvent, and the third component of the composition is preferably 40 mol% or less, more preferably 1 mol% or less, and most preferably no third. The inclusion compound of the component. The term "encapsulated compound" in the present invention means that the host compound forms an inclusion lattice, and the host compound is bonded by a bond other than a covalent bond to a species or two or more guest compounds. The material 'is more preferably a crystalline compound. The inclusion compound of the present invention containing a slow acidifying compound and (4) a compound may also be referred to as a salt formed from the compound of (4) and a compound of the formula. 153278.doc 201139358 As abbreviated as ' 5-perylene isophthalic acid is called "mpA", 2_phenyl ice methyl-5-hydroxymethylimidazole is called "2p4MHz". The term "encapsulated crystal lattice" as used herein means that the host compounds are bonded to each other by a bond other than a covalent bond, and a covalent bond is used in a gap of two or more molecules of the bonded host compound. The bond is bound to other molecules (guest or solvent, etc.), or other molecules and host compounds; or the host compound is bonded to other molecules (guests or solvents, etc.) by bonds other than covalent bonds, and bonds with other molecules In the gap of 2 or more molecules of the host compound, the host compound and/or other molecules (guest or solvent, etc.) are encapsulated by a bond other than the covalent bond. The inclusion compound of the present invention can be used as a hardener for resins such as polyester resins, epoxy resins, epoxy-polyacetal resins, and the like, and is particularly suitable as a hardener for epoxy resins. The sulphur epoxy resin composition can be suitably used for curing an epoxy resin, for example, an epoxy resin adhesive, a semiconductor sealing material, a liquid crystal sealing material, a laminated board for printed wiring, a varnish, (10) a material, and an ink. And other uses. ’ ' The inclusion compound of the present invention may be a liquid which is dissolved in a solvent, but is preferably a powder (precipitated in a solvent). By making it into a powder form, it can be used, for example, for a powder coating. The structure of the inclusion compound can be confirmed by thermal analysis (TG and DTA), infrared absorption spectroscopy (IR), X-ray diffraction (XRD) pattern, solid state NMR spectroscopy, and the like. Also, the composition of the inclusion compound can be analyzed by thermal analysis! It was confirmed by h_Nmr spectrum, high performance liquid chromatography (HPLC), elemental analysis, and the like. Further, when the ratio (purity) of the 1:2 inclusion compound is, for example, a composition comprising a 1:1 inclusion compound and a 1:2 inclusion compound, it may be 153278.doc, 10. 201139358 according to the purity (%) ==: 2 inclusion compound / (1 : i inclusion compound + i: 2 inclusion compound) x 100, calculated from the integral value of lH_NMR of the inclusion compound. As an example, the purity of the HIPA and 2P4MHZ: 2, the purity of the inclusion compound can be obtained by dividing the integral value of the hunger (10) 6 by the integral value of ppm (a), and obtaining it according to the following formula. 1. The purity (%) of the inclusion compound (2a/n> xi 〇〇 (carboxylic acid compound) The aromatic carboxylic acid compound is not particularly limited, and examples thereof include the following: benzoic acid, 2-methyl Benzoic acid, 3-mercaptobenzoic acid, 4·methylbenzoic acid, 2-ethyl benzoic acid, 3-ethylbenzoic acid, 4·ethylbenzoic acid, 2-n-propylbenzoic acid, 3-positive Propyl benzoic acid, 4-n-propylbenzoic acid, 2-butylphthalic acid, 3-butylphthalic acid, 4-butylbenzoic acid, 2-isopropylbenzoic acid, 3-isopropyl Benzoic acid, 4-isopropylbenzoic acid, 2-isobutylphthalic acid, 3-isobutylphthalic acid, 4-isobutylbenzoic acid, 2-perbenzoic acid, 3-hydroxybenzene Formic acid, 4-hydroxybenzoic acid, 2-nitrobenzoic acid, 3-nitrobenzoic acid, 4-nitrobenzoic acid, 2-nitrobenzoic acid decyl ester, methyl 3-nitrobenzoate, Methyl 4-nitrobenzoate, ethyl 2-nitrobenzoate, ethyl 3-nitrobenzoate, 4-nitrobenzoic acid, 2-nitrobenzoic acid C, 3-stone Schiffki propyl formate, 4-stone succinyl propyl acrylate, 2-succinyl benzoate, butyl 3-nitrobenzoate, 4-nitro Butyl phthalate, 2,3-dimethylbenzoic acid, 2,4-dimercaptoic acid 2,5-dimercaptobenzoic acid, 2,6-dimercaptobenzoic acid, 3, 4-dimethylbenzoic acid, 3,5-dimethylbenzoic acid, 3,6-dimethylbenzoic acid, 4,5-dimercaptobenzoic acid, 4,6-dimethylbenzoic acid , 2,3-diethyl 153278.doc 201139358 benzoic acid, 2,4-diethylbenzoic acid, 2,5-diethylbenzoic acid, 2,6-diethylbenzoic acid, 3,4 -diethylbenzoic acid, 3,5-diethylbenzoic acid, 3,6-diethylbenzoic acid, 4,5-diethylbenzoic acid, 4,6-diethylbenzoic acid, 2, 3-dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid, 2,5-dihydroxyindole acid, 2,6-dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 3,5-di Hydroxybenzoic acid, 3,6-dihydroxybenzoic acid, 4,5-dihydroxyindole acid, 4,6-dihydroxybenzoic acid; phthalic acid, 3-methylphthalic acid, 4-mercaptophthalic acid, 5-methylphthalic acid, 6-methylphthalic acid, 3-ethylphthalic acid, 4-ethylphthalic acid, 5-ethyl O-phthalic acid, 6-ethylphthalic acid, 3-n-propylphthalic acid, 4-n-propylphthalic acid Formic acid, 5·n-propyl phthalic acid, 6-n-propylphthalic acid, 3-butylphthalic acid, 4-butylphthalic acid, 5-butylphthalic acid , 6-butylphthalic acid, 3-isopropylphthalic acid, 4-isopropylphthalic acid, 5-isopropylphthalic acid, 6-isopropylphthalic acid, Isobutylphthalic acid, 4-isobutylphthalic acid, 5-isobutylphthalic acid, 6-isobutylphthalic acid, 3-hydroxyphthalic acid, 4_super Base of stearic acid, 5-hydroxyphthalic acid, 6-hydroxyphthalic acid, 3,4-dihydroxyphthalic acid, 3,5-dihydroxyphthalic acid, 3,6_two Hydroxyphthalic acid, 4,5-dihydroxyphthalic acid, 4,6-dihydroxyphthalic acid, 3-nitrophthalic acid, 4-nitrophthalic acid, 5-nitrogen Phthalic acid, 6-nitrophthalic acid, 3,4·dimethyl phthalic acid, 3,5-didecyl phthalic acid, 3,6-dimethyl phthalene Formic acid, 4,5-dimethylphthalic acid, 4,6-dimercaptophthalic acid; 153278.doc 12 • · 8 201139358 isophthalic acid, 2-methyl Isophthalic acid, 4-methylisophthalic acid, 5-methylisophthalic acid, 6-mercaptoisophthalic acid, 2-ethylisophthalic acid, 4-ethylisophthalic acid Dicarboxylic acid, 5-ethyl meta-dicarboxylic acid, 6-ethyl isophthalic acid, 2-n-propyl isophthalic acid, 4-n-propylisophthalic acid, 5-n-propyl isophthalic acid ,6-n-propylisophthalic acid, 2-isopropylisophthalic acid, 4·isopropylisophthalic acid, 5-isopropylisophthalic acid, 6-isopropylisophthalic acid Dicarboxylic acid, 2-butylisophthalic acid, 4-butylisophthalic acid, 5-butyl meta-2-decanoic acid, 6-butylisophthalic acid, isobutyl phthalic acid, 4-isobutylisophthalic acid, 5-isobutylisophthalic acid, 6-isobutyl meta-succinic acid, 4-tert-butylisophthalic acid, 5_third Base meta-benzoic acid, 6_t-butyl isophthalic acid, 2-hydroxyisophthalic acid, 4-hydroxyisophthalic acid, 5-hydroxyisophthalic acid, 6-hydroxy-p-dicarboxylic acid, 2'4-dihydroxyisophthalic acid, 2,5-dihydroxyisophthalic acid, 2,6-dihydroxyisophthalic acid, 4,5•dihydroxyisophthalic acid, 4, 6_ Dihydroxyisophthalic acid, 5,6-dihydroxymethanedicarboxylic acid, 2,4·dimethylm-xylylene phthalate, 2,5-dimethylisophthalic acid, 2,6-didecyl Meta-xylylene I 4,5-methyl-m-phthalic acid, 4,6-diindenyl stearic acid, 5'6--methylisophthalic acid, 2•nitro-m-xylylene phthalate, Substituted stearic dicarboxylic acid, 5-nitroisophthalic acid, "Schiffki dibenzoic acid, 2-methyl-p-phenylene terephthalate, 2. ethyl terephthalic acid, 2-n-propyl-p-benzene Dicarboxylic acid, isopropyl terephthalic acid, 2-butylene terephthalic acid, 2 • isobutyl palladium: formic acid, 2-transbasic p-dicarboxylic acid, 2,6-di-p-phenyl-p-dicarboxylic acid, a : methyl-p-xylylene phthalate, 2-nitroterephthalic acid, 1,2,3-benzenetricarboxya ruthenium 1,2'4-benzonic acid (stanoic acid), benzenetricarboxylic acid , υ, 4·笨 153278.doc 13· 201139358 Two oxic acid, loading, the present dicarboxylic acid, 3-hydroxy-1,2,4-benzenetricarboxylic acid, 5-di-oroxic acid, 6·yl-based- 1,2,4-benzenetricarboxylic acid, 12,4,5-benzenetetracarboxylic acid (pyromellitic acid); , formic acid 2-naphthoic acid, 2-methyl-1-naphthoic acid, 3-methyl -1-naphthyl:, 4-methyl-1-naphthoic acid," Naphthoic acid, "basinnaphthalene:,7·mercapto-1_naphthoic acid, 8-methylq•naphthoic acid, methyl-methyl-naphthylmethyl-2_naphthoic acid, 4-mercapto _2-naphthoic acid, 5-methyl-2-naphthoquinone, 6'methyl·2·naphthoic acid, 7-methyl-2•naphthoic acid, 8-methyl-2-naphthoic acid, 1'2 -naphthalene dicarboxylic acid, hydrazine, 3-naphthalene dicarboxylic acid, quinone-naphthalene dicarboxylic acid, iota, 5-naphthalenedicarboxylic acid, 1,6-naphthalene dicarboxylic acid, 〗 7, 7-naphthalenedicarboxylic acid, hydrazine , 8_naphthalene dicarboxylic acid, 2'3 naphthalene dicarboxylic acid, 2,4-naphthalene dicarboxylic acid, 2,5-naphthalenedicarboxylic acid, 2,6-naphthalenedicarboxylic acid, 2,7-naphthalene Carboxylic acid, 2,8-naphthalene dicarboxylic acid, 2-hydroxy-ι-naphthoic acid, 3-hydroxy-1-naphthoic acid, 4-hydroxy-1-naphthoic acid, 5-hydroxynaphthoic acid, cardioside-1 -naphthoic acid, 7-hydroxy-1-naphthoic acid, 8-hydroxy-1.naphthoic acid, dipyridyl-2-naphthoic acid, 3-carbyl-2-naphthoic acid, 4-pyridyl-2-naphthoquinone Acid, 5-cyano-2-naphthoic acid, 6-carbyl-2-naphthoic acid, 7-carbyl-2-naphthoic acid, 8-hydroxy-2-naphthoic acid, 1,2,4,5-naphthalene Carboxylic acid, 2,3-dihydroxynaphthoic acid, 2,4-dihydroxy-1-naphthoic acid, 2,5-dihydroxy-1-naphthoic acid, 2,6-di-yl-1-naphthoic acid, 2 , 7-two classics -1-naphthoic acid, 2,8-di-trans-yl-naphthoic acid, 3,4-dihydroxy-1.naphthoic acid, 3,5-dihydroxy-1-naphthoic acid, 3,6-di Base-1-caincarboxylic acid, 3,7-di-propyl-1-naphthoic acid, 3,8-di-trans-yl-naphthoic acid, 4,5-di-trans-naphthoic acid, 4,6- Di-mercapto-1-naphthoic acid ' 4,7-di-propyl-1-naphthoic acid, 4,8-di-yl-1-naphthoic acid, 5,6-dipyridyl-i-naphthoquinone 153278.doc -14- 201139358 酉文,5,7·dihydroxy-1·naphthoic acid, 5,8-dihydroxy-1-naphthoic acid, 6,7-dihydroxy_1~naphthoic acid, 6,8-dihydroxy_ Ι_naphthoic acid, 7,8-dihydroxy-1_naphthoic acid, indole 3-dihydroxy-2-naphthoic acid, 1,4-dihydroxy-2-naphthoic acid, 1,5-hydroxyhydroxynaphthoic acid, 1,6-dihydroxy-2-naphthoic acid, 1,7-dihydroxy-2-naphthoic acid, 1,8-dihydroxy-2-naphthoic acid, 3,4-dihydroxy-2-naphthoic acid, 3 , 5· monohydroxy-2-naphthoic acid, 3,6-dihydroxy-2-naphthoic acid, 3,8-dihydroxy-2•naphthyl, 4 < dihydroxy-2-naphthoic acid, 4, 6_Dihydroxy_2_naphthoic acid, 4,7-hydroxy-2-naphthoic acid, 4,8-dihydroxy-2-naphthoic acid, 5,6-dihydroxy-2-naphthoic acid, 5,7-di Hydroxy-2-naphthoic acid, 5,8-dihydroxy-2-naphthoic acid, 6,7-monohydroxy-2-naphthoic acid, 6,8-dihydroxy-2-naphthoic acid, 7,8-dihydroxy-2_cacocarboxylic acid, cyclohexanecarboxylic acid, hydrazine, 2•cyclohexanedicarboxylic acid, hydrazine , 3_cyclohexanedicarboxylic acid, hexamethylene acid, hydrazine, 1·cyclohexanedicarboxylic acid, 1,2-decahydronaphthalene dicarboxylic acid, l3-decahydronaphthalene dicarboxylic acid, 〖, 4_decahydrogen Naphthalene dicarboxylic acid, 1,5-decahydronaphthalene dicarboxylate, decahydronaphthalene dicarboxylic acid, 1,7-decahydronaphthalene dicarboxylic acid, hydrazine, 8-decahydronaphthalene dicarboxylic acid, and the like. It is also possible to use two kinds of these aromatic carboxylic acid compounds in combination, and to use one of the above-mentioned ones, which are preferably 'the following formula (IV) or the following group of phthalic acid compounds, and the aromatics represented by the following formulas (R9) (R6) N2
(COOH) m (m) (式中’ nl表示1〜4中之任一 n2表 示 '4中之任 J53278.doc -15- 201139358 整數;Re表示C1~C6烷基、硝基或羥基) [化 10] (R7)m2 (COOH)ml (N) (式中,ml表示1〜4中之任一整數;m2表示0〜2中之任一整 數;R?表示C1〜C6烷基、硝基、羥基或下式所表示之基, [化 11](COOH) m (m) (wherein nl represents any of 1 to 4, n2 represents an integer of J53278.doc -15-201139358 in '4; Re represents a C1~C6 alkyl group, a nitro group or a hydroxyl group) [ (10) (R7) m2 (COOH) ml (N) (wherein ml represents any integer of 1 to 4; m2 represents any integer of 0 to 2; R? represents C1 to C6 alkyl, nitrate a base, a hydroxyl group or a group represented by the following formula, [Chem. 11]
(COOH)q (式中’ q表示1或2之整數;*表示鍵結位置))。 6 R7之C1〜C6烧基包括環烧基,具體可列舉:甲基、 乙基、正丙基、異丙基、環丙基、正丁基、異丁基第二 丁基、第二丁基、環丁基、環丙基甲基、正戊基、異戊 基、2-甲基丁基、新戊基、丨_乙基丙基、正己基、異己 基、4·甲基戊基、3-曱基戊基、2·甲基戊基、i•甲基戊 基、3,3_二甲基丁基、2,2·二甲基丁基等。 土 化=:式(ΙΠ)中,較佳為下述式(1)所表示之芳香族緩酸 [化 12] 153278.doc 201139358(COOH)q (wherein 'q represents an integer of 1 or 2; * denotes a bonding position)). 6 C7~C6 alkyl group of R7 includes a cycloalkyl group, and specifically, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a cyclopropyl group, a n-butyl group, an isobutyl group, a second butyl group, and a second group are mentioned. Base, cyclobutyl, cyclopropylmethyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, oxime-ethyl, n-hexyl, isohexyl, 4·methylpentyl , 3-mercaptopentyl, 2·methylpentyl, i•methylpentyl, 3,3-dimethylbutyl, 2,2·dimethylbutyl, and the like. In the soil == formula (ΙΠ), it is preferably an aromatic acid retardation represented by the following formula (1) [Chemical 12] 153278.doc 201139358
COOHCOOH
式中,R!表示C1〜C6烷基、C1〜C6烷氧基或羥基。 作為C1-C6烷基,較佳為Cl〜C4烷基,亦可具有取代 基。C1〜C6烷基包括環烷基,具體可列舉:曱基、乙基、 正丙基、異丙基、環丙基、正丁基、異丁基、第二丁基、 第三丁基、環丁基、環丙基甲基、正戊基、異戊基、2·曱 基丁基、新戊基、1-乙基丙基、正己基、異己基、4·甲基 戊基、3-曱基戊基、2-甲基戊基、1-曱基戊基、3,3-二曱 基丁基、2,2-二曱基丁基、1,1-二曱基丁基、1,2-二甲基丁 基、1,3-二曱基丁基、2,3-二甲基丁基、1-乙基丁基、2-乙 基丁基等。 作為C1〜C6烷氧基’較佳為C卜C4烷氧基,亦可具有取 代基。作為C1~C6烷氧基,具體可列舉:甲氧基、乙氧 基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁 氧基、第三丁氧基、正戊氧基、異戊氧基、2_曱基丁氧 基、1-乙基丙氧基、2-乙基丙氧基、新戊氧基、正己氧 基、4-曱基戊氧基、3-曱基戊氧基、2-甲基戊氧基、3,3-二曱基丁氧基、2,2-二曱基丁氧基、ι,ι_二曱基丁氧基、 1,2-二甲基丁氧基、1,3-二甲基丁氧基、2,3-二甲基丁氧基 等。 (咪唑化合物) 本發明中所使用之咪唑化合物為下述式(11)所表示之咪 153278.doc •17- 201139358 °坐化合物及β米唾淋化合物。 [化 13]In the formula, R! represents a C1 to C6 alkyl group, a C1 to C6 alkoxy group or a hydroxyl group. The C1-C6 alkyl group is preferably a C1-C4 alkyl group, and may have a substituent. The C1-C6 alkyl group includes a cycloalkyl group, and specific examples thereof include a mercapto group, an ethyl group, a n-propyl group, an isopropyl group, a cyclopropyl group, a n-butyl group, an isobutyl group, a second butyl group, and a third butyl group. Cyclobutyl, cyclopropylmethyl, n-pentyl, isopentyl, 2, nonylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, isohexyl, 4·methylpentyl, 3 -decylpentyl, 2-methylpentyl, 1-decylpentyl, 3,3-dimercaptobutyl, 2,2-dimercaptobutyl, 1,1-didecylbutyl, 1,2-dimethylbutyl, 1,3-dimercaptobutyl, 2,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, and the like. The C1-C6 alkoxy group is preferably a C-C4 alkoxy group, and may have a substituent. Specific examples of the C1 to C6 alkoxy group include a methoxy group, an ethoxy group, a n-propoxy group, an isopropoxy group, a n-butoxy group, an isobutoxy group, a second butoxy group, and a third butoxy group. , n-pentyloxy, isopentyloxy, 2-hydrinobutoxy, 1-ethylpropoxy, 2-ethylpropoxy, neopentyloxy, n-hexyloxy, 4-decylpentane Oxyl, 3-mercaptopentyloxy, 2-methylpentyloxy, 3,3-dimercaptobutoxy, 2,2-dimercaptobutoxy, ι,ι-didecyloxy Base, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,3-dimethylbutoxy and the like. (Imidazole compound) The imidazole compound used in the present invention is a compound represented by the following formula (11): 153278.doc • 17-201139358 ° sitting compound and β-mirryl compound. [Chem. 13]
Ν、 (Π) ΝΝ, (Π) Ν
•R2 具體而言,含有下述式(II)之結構。 [化 14]• R2 specifically contains a structure of the following formula (II). [Chem. 14]
式中’R_2表示氫原子、Cl~C 10烧基 或氰基乙基,較佳為氫原子。 芳基、芳基烷基 作為C1〜C10烷基,較佳為C1〜C6烷基,f 1 , 亦可具有取代 基。作為C1〜C10烷基’具體可列舉:甲基、 己基、正丙 基、異丙基、正丁基、第二丁基、異丁基、 币二丁基、正 戊基、正己基、壬基、異壬基、癸基等。 芳基係指單環或多環之芳基。此處,於為多環芳基之情 形時,除完全不飽和之基以外,#包括部分飽和之基。例 如可列舉·苯基、蔡基、ϋ基、節基、二|^基、四氮蔡 基等。該#中,較佳為C6〜C10芳基。又,芳基亦可具有 取代基。 方基烷基係上述芳基與烷基鍵結而成之基,可列舉:苄 153278.doc 201139358 基、苯乙基、3-苯基正丙基、丨·苯基正己基、萘基甲 基萘基乙基、萘-2-基正丙基、茚_1_基ψ基等。該 等中,較佳為C6〜C10芳基C1〜C6烷基。又,芳基烷基亦可 具有取代基。 R3〜R5分別獨立表示氫原子、硝基、鹵素原子、CNC20 烷基、經羥基取代之C1〜C20烷基、芳基、芳基烷基或 C1〜C20之醯基。 作為C1〜C20烷基,可列舉:甲基、乙基、正丙基異 丙基、正丁基、第二丁基、異丁基、第三丁基、正戊基、 正己基、壬基、異壬基、癸基、月桂基、+三烧基、肉豆 蔻基、十五烷基、棕櫚基、十七烷基、硬脂基等❶較佳為 C1〜C10烷基。 作為芳基及芳基烷基,可列舉與尺2之基相同的基。 所謂CK20酿基,係指氫原子、烷基、烯基、炔基、 芳基、或雜芳基等與羰基鍵結而成之基。作為醯基,例如 可列舉:曱醯基;乙醯基、丙醯基、丁醯基'戊醯基、己 酿基、庚酿基、辛醯基、壬酿基、癸醯基、3•曱基壬酿 基、8-曱基壬酿基、3·乙基辛醯基、3,7•二甲基辛醯基、 十-烷醯基、十二烷醯基、十三烷醯基、十四烷醯基、十 五烧酿基、十六烧醮基、L甲基十五㈣基、14•甲基十五 烷醯基、13,13-二曱基十四烷醯基、十七烷醯基、15_甲基 十六烷醯基、十八烷醯基、i-甲基十七烷醯基、十九烷醯 基、二十烷醯基及二十一烷醯基等烷基羰基;丙烯醯基、 甲基丙稀喊、烯丙醯基、桂皮醯基㈣基絲;乙快基 153278.doc -19- 201139358 幾基、丙快基羰基等炔基羰基;苯甲醯基、萘基羰基、聯 苯基幾基、蒽基羰基等芳基羰基;2_π比啶基羰基、噻吩基 幾基等雜芳基羰基等。該等中,較佳為cl〜C2〇(含羰基)醯 基,尤佳為C1〜C6醯基。 具體而言’作為式(Π)所表示之咪。坐化合物,可列舉: 咪唑、2-乙基-4-甲基咪唑、2_曱基咪唑、j苄基_2_曱基咪 唑、2-十七烷基咪唑、2_十一烷基咪唑、2_苯基_4_甲基_5_ 羥基曱基咪唑' 2-苯基咪唑、2·笨基_4_甲基咪唑、1 -苄基_ 2-笨基咪唑、1,2-二曱基咪唑、卜氰基乙基_2_甲基咪唑、 1-氰基乙基-2-乙基-4-甲基咪唑、丨_氰基乙基_2十一烷基 咪唑、1-氰基乙基-2-苯基咪唑、2_苯基·4,5•二羥基曱基咪 唑等,較佳為2-乙基-4-甲基咪唑、2-甲基咪唑、丨_苄基_2· 甲基咪唑、2-十七烷基咪唑、2_十一烷基咪唑、2_苯基_4· 曱基-5-羥基甲基咪唑、2_苯基咪唑或2_苯基_4,5_二羥基甲 基口米。坐。 作為式(II)所表示之咪唑啉化合物,可列舉:2_曱基咪 2-苯基咪㈣、2•十—烧基㈣琳、2•十七烧基味 唑啉、2-乙基咪。坐啉、2_異丙基啼。坐啉、2,心二曱基味唾 咐、2-苯基_4·甲基咪唾琳等,較佳為2•甲基咪。坐琳或2_笨 基°米唾琳。 (羧酸化合物対咪唑化合物夕】. α物之1 . 2包接化合物或其組合物 之製造方法) 羧酸化合物與味錢合物之莫耳比實質上為丄:2之包接 化合物或其組合物可藉由以下方法等而獲得。 153278.doc ⑧ •20· 201139358 ⑴向味唑化合物中添加羧酸化合物之醇溶液之方法 ⑺向咪吃化合物之醇液中添加幾酸化合物之方法 以下說明(1)之方法之詳細内容。 向咪唑化合物中’一邊視需要進行攪拌,—邊添加羧酸 化合物之醇溶液。m酸化合物之醇溶液之添加並 制’通常以5〜120分鐘連續或分割添加。 ‘,,、特 於添加羧酸化合物之醇溶液後’視需要於室溫下放置 0〜5小時’於室溫〜4〇t下加熱〇〜5小時或加熱回流〇 時。 作為缘酸化合物與咪嗤化合物之調配比例,相對於緩酸 化合物(主體)1莫耳,咪唑化合物(客體)較佳為〇丨〜5〇莫 耳’更佳為0.5〜3.0莫耳。 、 作為醇溶劑’可例示曱醇、乙醇、正丙醇等低級醇,較 佳為甲醇。使用量通常相對於羧酸化合物,以重量換算為 0.5〜50倍量。 ^ 加熱處理或加熱回流處理後之步驟例如可藉由單純停止 加熱或加熱回流處理而使固體化合物析出,較佳為加熱後 於室溫下放置一晚。於使固體化合物析出後,例如藉由過 濾乾燥而獲得目標化合物。 以下說明(2)之方法之詳細内容。 將咪唑化合物懸浮或者溶解於醇中(將醇懸浮液及醇溶 液稱為醇液)後,一邊視需要進行攪拌,一邊添加羧酸化 合物。羧酸化合物之添加並無特別限制,通常以5〜12〇分 鐘連續或分割添加。 153278.doc -21 - 201139358 添加羧酸化合物後,視需要於室溫下放置0〜5小時,於 室溫〜40。(:下加熱〇〜5小時或加熱回流〇〜5小時。 作為緩酸化合物與咪唑化合物之調配比例,相對於敌酸 化合物(主體)1莫耳,咪唑化合物(客體)較佳為〇丨〜5 〇莫 耳’更佳為0.5〜3.0莫耳。 作為醇溶劑,可列舉甲醇、乙醇、正丙醇等低級醇,較 佳為甲醇。使用$通常相對於致酸化合物,以重量換算為 0.5〜50倍量。 作為參考,將HIPA與2p4MHZ之莫耳比為i : i之包接化 合物之製造方法記載於下文。 (HIPA與2P4MHZ之莫耳比為i :丄之包接化合物之製造方 法) HIPA與2P4MHZ之莫耳比實質上僅為丨:i之包接化合物 可藉由以下方法等而獲得。 將HIPA溶解於醇中後,—邊視需要進行㈣,—邊添加 2P4MHZ。2P4MHZ之添加並無特別限制,通常為5分鐘以 上,較佳為以5分鐘〜12〇分鐘連續或分割添加。 於添加2P4MHZ後,視需要於室溫下放置〇〜5小時,於室 溫〜40°C下加熱〇〜5小時或加熱回流〇〜5小時。 作為1 . 1包接化合物之製造方法申之出與 調配比例,相對於HIPA(主體)丨莫耳,2P4MHZ(客體)較佳 為0.1〜5.0莫耳,更佳為0.5〜3.0莫耳。 作為1 . 1包接化合物之製造方法_之醇溶劑,可例示甲 醇、乙醇、正丙醇等低級醇,較佳為甲醇。使用量通常相 153278.doc 2 ⑧ 201139358 對於HIPA而為〇 5〜5〇倍量。 力…、處理或加熱回流處理後之步驟例如可藉由單純停止 :熱或加熱回流處理而使固體化合物析出,較佳為加熱 於至溫下放置—晚。使固體化合物析出後,例如藉由 進行過濾乾燥而獲得目標化合物。 曰 (硬化性環氧樹脂組合物) 本發明之包接化合物或其組合物可用作環氧樹脂硬化劑 或硬化促進劑,與環氧樹脂混合,例如用作半導體密封 劑0 用作半導體密封劑等之硬化環氧樹脂組合物含有環氧樹 脂、本發明之包接化合物、及視需要之其他添加劑。 Ο環氧樹脂 作為環氧樹脂,可使用先前公知之各種聚環氧化合物, 例如可列舉:雙(4_羥基苯基)丙烷二縮水甘油醚、雙(4_羥 基3’5 — >臭本基)丙烧·一縮水甘油趟、雙(4 -經基苯其)乙烧 二縮水甘油醚、雙(4·羥基苯基)甲烷二縮水甘油醚、間苯 二紛二縮水甘油醚、間苯三酚三縮水甘油醚、三經基聯苯 三縮水甘油醚、四縮水甘油基二苯曱酮、雙間笨二酚四縮 水甘油醚、四曱基雙酚Α二縮水甘油醚、雙盼c二縮水甘 油醚、雙酚六氟丙烷二縮水甘油醚、13•雙"^2,3-環氧基 丙氡基)-1-三氟甲基-2,2,2-三氟乙基]笨、1,4_雙[1_(2,3_環 氧基丙氧基)-1-三氟甲基-2,2,2-三氟曱基]笨、4,4,_雙(2,3_ 環氧基丙氧基)八氟聯苯、苯酚酚醛清漆型雙環氧化合物 等芳香族系縮水甘油醚化合物;脂環族二環氧基縮搭、環 153278.doc •23· 201139358 族二環氧己二酸脂酿、脂環族二環氧缓酸醋、二氧化乙婦 基環己烤等脂環式聚環氧化合物;鄰苯二甲酸二縮水甘油 酯、四氫鄰苯二甲酸二縮水甘油酯、六氫鄰苯二甲酸二縮 水甘油酿、鄰苯二甲酸二甲基縮水甘油醋、六氣鄰苯二甲 酸二甲基縮水甘油醋、對經基苯甲酸二縮水甘油醋、環戊 nm縮水甘油6旨、二聚酸縮水甘油醋等縮水甘 油醋化合物;二縮水甘油基苯胺、二縮水甘油基甲苯胺、 三縮水甘油基胺基苯紛、四縮水甘油基:胺基二苯基甲 烷、二縮水甘油基三漠苯胺等縮水甘油基胺化合物;二縮 水甘油基乙内醯膝、縮水甘油基縮水甘油氧基烧基乙内酿 脲、異氰尿酸三縮水甘油酯等雜環式環氧化合物等。 又,作為液狀之環氧樹脂,例如可列舉:(聚)乙二醇二 縮水甘油ϋ、(聚)丙二醇二縮水甘油_、三經甲基丙&三 縮水甘油醚等聚伸烷基醚型環氧化合物;二聚酸二縮水甘 油S曰、鄰苯一甲酸二縮水甘油醋、四氣鄰苯二甲酸二縮水 甘油醋等縮水甘油醋型環氧化合物;(甲基)丙稀酸縮水甘 由西曰烯丙基縮水甘油醚等單聚物或該單體與其他軟質不 飽洋單體之共聚物等。所謂軟質不飽和單體,係指其均聚 物之玻璃轉移溫度未達6〇〇c者,例如可列舉:丙烯酸甲 7、丙㈣乙s旨、(甲基)㈣酸丁 8旨、(甲基)丙烯酸異丁 酯、(甲基)丙烯酸2-乙基己酯、甲基丙烯酸月桂酯等。 2)無機填充劑 本發明之環氧樹脂組合物可含有上述包接化合物及環氧 樹月曰又,亦可為除包接化合物及環氧樹脂以外亦含有無 153278.doc ⑧ •24- 201139358 機填充剤之環氧樹脂組合物 作為無機填充劑,並無 璃、蕤a + η:# n艮制,例如可列舉:石英玻 ^错由火焰熔融而獲得之跬#匕 法等所製造之球形二氧切、二::、藉由溶谬凝谬 石粉、氮介叙^ 、·'〇日日一氧化矽、氧化鋁、滑 使用,ITT# 氧匕鎂、矽酸鎂等,該等可單獨 优用,亦可使用2種以上。 3)硬化劑或效果促進劑 作為本發明之環氧樹脂組合物中可含有之硬化劑,只要 2可使與環氧樹财之環氧基反應而使環氧樹脂硬化之化 ιΓ/無特別限制°同樣地,作為本發明之環氧樹脂組 °人可含有之硬化促進劑,只要為促進上述硬化反應之 ,°物,則無特別限制。作為此種硬化劑或硬化促進劑, 可自先則作為環氧樹脂之硬化劑或硬化促進劑而慣用者中 選用任意者。例如可列舉:脂肪族胺類、脂環式及雜環式 月女類、方香族胺類、改性胺類等胺系化合物;呼、唑系化合 物、咪唑啉系化合物、醯胺系化合物、酯系化合物、笨酚 系化合物、醇系化合物、硫醇系化合物、㈣系化合物、硫 醚系化合物、I系化合物、硫脲系化合物、路易斯系化: 物、碟系化合物、酸針系化合物、鑌鹽系化合物、活性石夕 化合物-鋁錯合物等。 作為硬化劑或硬化促進劑,具體而言,例如可列舉以 化合物。 153278.doc -25· 201139358 作為脂肪族胺類,例如可列舉:乙二胺、u-丙二胺、 二乙二胺、Μ_τ二胺、16己二胺、二乙三胺三乙四 胺四乙五胺、一丙二胺、二甲基胺基丙胺、二乙基胺基 丙胺二甲基·丨,6.己二胺、戊二胺、雙(2_二甲基胺基乙 土)驗五曱基一乙二胺、院基三級單胺、1,4-二氮雜雙環 (2,2,2)辛燒(三乙二胺)、ν,ν,ν,,ν._四甲基.Μ己二胺、 队N’N,,y四甲基丙二胺、ν,ν,ν,界四甲基乙二胺、Ν,Ν_ 甲基%己胺、一丁基胺基丙胺、二甲基胺基乙氧基乙氧 基乙醇、三乙醇胺、二甲基胺基己醇等。 作為知環式及雜環式胺類,例如可列舉κ "底呼、 薄何烷二胺' 異佛爾,二胺、甲基咪啉、乙基咪啉、 Ν,Ν,Ν’·-三(二甲基胺基丙基)六氫均三畊、3,9_雙(3_胺基 丙土)2’4,8,1〇-四氧雜螺(5,5)_|_ 一烷加合物、N—胺基乙基 底井一甲基胺基乙基哌11井、雙(4-胺基環己基)甲烷、 Ν,Ν’-二曱基哌Ρ井、二氮雜雙環[4.5.0]十一烯_7等。 作為芳香族胺類,例如可列舉:鄰苯二胺、間苯二胺、 對苯二胺、二胺基二笨基曱烷、二胺基二笨基颯、苄基曱 基胺、二甲基苄基胺、間二甲苯二胺、吡啶、甲基吡啶、 α-曱基苄基甲胺等。 作為改性胺類,例如可列舉:環氧化合物加成多胺、邁 克爾加成多胺、曼尼希加成多胺、硫脲加成多月安、酮封端 多胺、雙氰胺、胍、有機酸醯肼、二胺基順丁烯二腈、胺 醯亞胺、三氟化硼-哌啶錯合物、三氟化硼-單乙基胺錯合 物等。 153278.doc -26· 201139358 作為咪唑系化合物,例如可列舉:咪唑、卜曱基咪唑、 2-甲基咪唑、3-甲基咪唑、4_甲基咪唑、5_甲基咪唑、卜 乙基咪唑、2-乙基咪唑、3_乙基咪唑、乒乙基咪唑、5_乙 基咪唑、卜正丙基咪唑、2-正丙基咪唑、丨_異丙基咪唑、 2-異丙基咪唑、1-正丁基咪唑、2_正丁基咪唑、丨·異丁基 咪唑、2-異丁基咪唑、2-十—烷基_1H_咪唑、2_十七烷基_ m-咪唑、i,2-二甲基味唑、^二甲基咪唑、2,4_二甲基 咪唑、2-乙基-4-曱基咪唑、!·笨基咪唑、2·苯基•咪 唑、4-甲基-2-苯基-mu 2_苯基·4·甲基咪唾、i•节 基_2_甲基Μ、^基1笨基味„坐、κ氮基乙基_2•甲基 味。坐、1-氰基乙基-2-乙基_4·曱基咪唑、卜氛基乙基_2_十 一烷基味吐、i-氰基乙基-2_笨基咪啥、2_苯基咪唾異三 聚氰酸加成物、2-甲基咪唑_異三聚氰酸加成物、2·苯基_ 4,5-二經基甲基Μ、2.笨基|甲基_5_減甲基w、卜 氰基乙基-2-苯基·4,5·二(2、氰基乙氧基)甲基咪。圭、i•十二 院基·2·甲基m氣化咪哇鑷、苯基咪》坐鹽酸 鹽等。 作為㈣化合物,例如可列舉:2甲㈣。坐琳、2_ 苯基°米》坐琳等。 作為酿胺系化合物,例如可列舉藉由二聚酸與多胺之縮 合而獲得之聚醯胺等。 v 化合物’例如可列舉緩酸之芳基及硫芳基酉旨之 類的活性羰基化合物等。 作為編化合物、醇系化合物、硫醇系化合物、謎系 153278.doc •27. 201139358 化合物、及硫醚系化合物,例如作為苯酚樹脂硬化劑,可 列舉.苯酚芳烧基樹脂、萘酚芳烷基樹脂等芳烷基型酚樹 脂,苯酚酚醛清漆樹脂、甲酚酚醛清漆樹脂等酚醛清漆型 苯酚樹脂,該等之改性樹脂、例如環氧基化或者丁基化之 酚醛清漆型苯酚樹脂等,二環戊二烯改性苯酚樹脂、對二 甲苯改性苯酚樹脂、三苯酚烷型苯酚樹脂、多官能型苯酚 樹脂等。又,多元醇、多元硫醇、多硫化物、2_(二甲基胺 基甲基苯酚)、2,4,6-三(二甲基胺基甲基)苯酚、2,4,6_三 (二甲基胺基甲基)苯酚之三(2·乙基己基)鹽酸鹽等。 作為腺系化合物、硫腺系化合物、路易斯系化合物,例 如可列舉·丁基化脈、丁基化三聚氰胺、丁基化硫腺、三 氟化侧等》 夕1〗舉有機膦化合物 、丁基膦等烷基膦’苯基膦等-級膦;二甲基膦、二 :膦等:烷基膦、二苯基膦、甲基乙基膦等二級膦;三 土膦一乙基膦、三苯基膦等三級膦等。 :為酸酐系化合物,例如可列舉:鄰苯二甲酸酐、四 本-甲酸酐、六氫鄰笨二甲酸酐 酐、甲其丄祭抑# 風耶本—甲 肝、甲其甲酸野、内亞甲基四氫鄰苯二甲 亞甲2内亞甲基四氣鄰笨二曱酸酐、順丁婦二酸肝、 酐、:_丁烯一酸酐、偏苯三酸酐、氯菌酸酐、均笨四 -烯基琥珀酸酐、二苯甲酮四羧酸酐 (偏苯三酸野醋)、甘油三(偏苯三酸酐醋 :: 缓酸奸、聚壬二酸酐等。 甲基環己婦 153278.doc ⑧ •28· 201139358 又’作為鐵鹽系化合物、及活性碎化合物_紹錯合物, =如可列舉.芳基重氮鏽鹽、二芳基填鑌鹽、三芳基疏 鹽、三笨基矽烷醇-鋁錯合物、三苯基甲氧基矽烷·鋁錯合 物、過氧化碎燒錯合物、_ — w ^ 二本基>6夕烧醇-三(水楊駿酸) I呂錯合物等。 作為上述硬化劑或硬化促進劑,尤佳為使用胺系化合 物"米唾系化合物、苯盼系化合物。苯1系化合物中,更 佳為使用苯酚樹脂硬化劑。 4)其他添加劑 本發明之環氧樹脂組合物中,除上述者以外,視需要亦 可調配塑化劑、有機溶劑、反應性稀釋劑、增量劑、填充 Μ、增強劑、顏料、難燃化劑、增稠劑及脫模劑等各種添 加劑。作為其他添加劑,可列舉:乙烯基三甲氧基矽烷、 乙烯基三乙氧基矽烷、γ-縮水甘油氧基丙基三甲氧基矽 烷、γ-縮水甘油氧基丙基三乙氧基矽烷、γ_曱基丙烯醯氧 基丙基二甲氧基石夕烧、γ-甲基丙烯醯氧基丙基三乙氧基矽 烷、γ-胺基丙基三甲氧基矽烷、γ·胺基丙基三乙氧基矽 烧、Ν-β-(胺基乙基)-γ-胺基丙基三甲氧基石夕烧、Ν_β_ (胺基 乙基)-γ-胺基丙基三乙氧基矽烷、Ν_苯基_γ_胺基丙基三甲 氧基石夕烧、Ν-苯基-γ-胺基丙基三乙氧基石夕烧、丫_疏基丙基 三曱氧基矽烷、γ-疏基丙基三乙氧基矽烷等矽烷偶合劑; 碳酸氫鈣、輕質碳酸鈣、天然二氧化矽、合成二氧化石夕、 熔融二氧化矽、高嶺土、黏土、氧化鈦、硫酸鋇、氧化 鋅、虱氧化銘、氫氧化鎂、滑石粉、雲母、碎灰石、鈦酸 153278.doc •29- 201139358 鉀、硼酸鋁、海泡石、硬矽鈣石等填充劑;nbr、聚丁二 烯、氯丁二烯橡膠、聚矽氧、交聯NBR、交聯BR、丙烯酸 系、芯-殻型丙烯酸系、胺基甲酸酯橡膠、聚酯彈性體、 含官能基之液狀NBR、液狀聚丁二烯、液狀聚酯、液狀多 硫化物、改性聚矽氧、胺基甲酸酯預聚物等彈性體改性 劑; 六溴環癸烷、雙(二溴丙基)四溴雙酚A、異氰尿酸三(二 漠丙基)酯、磷酸三(三溴新戊基)酯、十溴二苯基氧化物、 雙(五溴苯基)乙烷、三(三溴苯氧基)三啩、伸乙基雙(四溴 鄰苯二曱酿亞胺)、聚溴苯基茚烷、溴化聚苯乙烯、四溴 雙紛A聚碳酸酯、溴苯環氧乙烷、聚丙烯酸五溴苄酯、磷 酸三苯酯、磷酸三曱苯酯、磷酸三(二甲苯基)酯、磷酸甲 苯二苯酯、磷酸二曱苯二苯酯、磷酸曱苯雙(2,6_二甲苯) 酯、磷酸2-乙基己酯二苯酯、間苯二酚雙(二苯基磷酸 醋)、雙紛A雙(二苯基磷酸酯)、雙酚a雙(二曱苯基磷酸 酯)、間苯二酚雙(二_2,6_二曱苯基磷酸酯)、磷酸三(氣乙 基)醋、磷酸三(氣丙基)酯、磷酸三(二氯丙基)酯、磷酸三 (三溴丙基)酯、二乙基-N,N-雙(2·氫氧基乙基)胺基曱基膦 酸酯、經陰離子草酸處理之氫氧化鋁、經硝酸鹽處理之氫 氧化鋁、經高溫熱水處理之氫氧化鋁、經錫酸表面處理之 水合金屬化合物、經鎳化合物表面處理之氫氧化鎂、經聚 石夕氧聚合物表面處理之氫氧化鎮、pr〇c〇bite、經多層表面 處理之水合金屬化合物、經陽離子聚合物處理之氫氧化鎂 等難燃劑;高密度聚乙烯、聚丙烯、聚苯乙烯、聚曱基丙 153278.doc 201139358 稀酸曱酿、聚氣乙烯、尼龍6,6、聚_、聚_、聚酸 醯亞胺、聚對苯二甲酸丁二醋、聚賴,、聚碳酸醋、聚 礙等工程塑膠;塑化劑;正丁基縮水甘油峻、苯基縮水甘 油醚、氧化苯乙烯、第三丁基苯基縮水甘油醚、二環戊二 :二環氧化物、苯酚、甲酚、第三丁基苯酚等稀釋劑;增 量劑;增強劑;著色劑;增稠劑;高級脂肪酸、高級脂肪 酸醋、高級脂肪酸鈣等、例如巴西棕櫚蠟或聚乙烯系蠟等 脫模劑等。該等添加劑之調配量並無特別限^,可在獲得 本發明之效果的限度内適宜決定調配量。 進而’本發明之環氧樹脂組合物中’除環氧樹脂以外, 亦可含有其他樹脂。作為其他樹脂’可列舉:聚酿樹脂、 丙烯酸系樹脂、矽系樹脂、聚胺基甲酸酯系樹脂等。 5)環氧樹脂組合物及其硬化物之調製 關於環氧樹脂與本發明之包接化合物或其組合物之調配 比例’相對於環氧樹脂之環氧基環1莫耳,包接化合物戍 其組合物中之咪唑化合物的含量較佳為〇〇ι〜ι〇莫耳更 佳為0·1〜i.0莫耳,更佳為0.3〜1.0莫耳。 又,環氧硬化樹脂形成驗合㈣藉由將環氧樹脂與本 發明之包接化合物或其組合物混合而製造,但為了形成充 :混合狀態’通常於60〜剛。C左右之溫度下進行加熱而混 二:環氧硬化樹脂之製造中’此時之溫度下之單液穩定 十憂仔重要。所製造之環氧樹脂組合物 方法,可為固形亦可為液狀。 成及h 作為環氧硬化樹脂形成用組合物之硬化法,只要為加熱 153278.doc -31 · 201139358 處理環氧硬化樹脂形成用組合物而使其硬化之方法,則無 特別限制,通常加熱處理之加熱溫度為60〜250°C。 實施例 以下,對實施例進行說明,但本發明之技術範圍並不限 定於該等實施例。 再者,以下之實施例中,iNMR係使用DMSO-d6或者 MeOH-d4作為測定溶劑,且於25°C下進行測定。 1包接化合物之製造 [合成實施例1] 向燒瓶中添加2P4MHZ 20.67 g(109.8 mmol)後,一邊攪 拌,一邊添加將HIPA 20 g(l 09.8 mmol)溶解於曱醇170 ml 中而獲得之液體的一半。利用甲醇11 mL進行清洗,於室 溫下放置0.5小時後,一邊攪拌,一邊添加剩餘之HIPA甲 醇溶液,利用甲醇11 mL進行清洗,於室溫下放置0.5小時 後,加熱回流3小時。其後,於室溫下放置一晚後,進行 過濾、真空乾燥,藉此獲得生成物28.89 g(產率71%)。藉 由1HNMR、X線繞射及熱分析(DSC)分析所獲得之生成 物,結果該生成物係HIPA : 2P4MHZ為1 : 2之包接化合物 之結晶。又,1 : 2包接化合物之純度為91%。將所獲得之 包接化合物之溫度變化之熱分析(DSC)圖表示於圖1。 [合成實施例2] 向於燒瓶中投入2P4MHZ 20.67 g(109.8 mmol)與曱醇130 ml並進行混合而獲得之醇液中,一邊攪拌,一邊以20分鐘 添加HIPA 10 g(54.9 mmol)。於室溫下放置0.5小時後,加 153278.doc -32· ⑧ 201139358 熱回流3小時。其後,於室溫下放置一晚後,進行過濾、 真空乾燥,藉此獲得生成物29.91 g(產率97.5%)。藉由 WNMR、X線繞射及熱分析(DSC)分析所獲得之生成物, 結果該生成物係HIPA : 2P4MHZ為1 : 2之包接化合物之結 晶。又,1 : 2包接化合物之純度為97%。將所獲得之包接 化合物之溫度變化之熱分析(DSC)圖表及iNMR圖表示於 圖2 -1及圖2 - 2。 [合成實施例3] 向燒瓶中添加2P4MHZ 20.67 g(109.8 mmol)後,一邊攪 拌,一邊以15分鐘添加將HIPA 10 g(54.9 mmol)溶解於甲 醇130 ml中而獲得之液體。於室溫下放置0.5小時後,加熱 回流3小時。其後,於室溫下放置一晚後,進行過濾、真 空乾燥,藉此獲得生成物29.74 g(產率97%)。藉由 hNMR、X線繞射及熱分析(DSC)分析所獲得之生成物, 結果該生成物係HIPA : 2P4MHZ為1 : 2之包接化合物之結 晶。又,1 : 2包接化合物之純度為99%。將所獲得之包接 化合物之溫度變化之熱分析(DSC)圖表及]HNMR圖表示於 圖3-1及圖3-2。 [合成實施例4] 除使用未經取代之咪0坐(以下稱為Im)7.48 g(109.8 mmol) 代替2P4MHZ以外,與合成實施例2同樣地獲得HIPA : Im 為1 : 2之包接化合物。又,1 : 2包接化合物之純度為 77%。將所獲得之包接化合物之溫度變化之熱分析(DSC) 圖表及iNMR圖表示於圖4-1及圖4-2。 153278.doc -33- 201139358 [合成參考例1](1 : 1包接化合物之製作) 向於燒瓶中投入HIPA 20 g( 109.8 mmol)與甲醇126 ml並 進行混合而獲得之溶液中,一邊攪拌,一邊以1 5分鐘添加 2P4MHZ 20.67 g(109.8 mmol)。於室溫下放置2小時後,加 熱回流3小時。其後,於室溫下放置一晚後,進行過濾、 真空乾燥,藉此獲得生成物39.56 g(產率97.3%)。藉由 'HNMR、X線繞射及熱分析(DSC)分析所獲得之生成物, 結果該生成物係HIPA : 2P4MHZ為1 : 1之包接化合物之結 晶。又,1 : 2包接化合物之純度為0%。將所獲得之包接 化合物之溫度變化之熱分析(DSC)圖表示於圖5。 [合成參考例2] 除使用lm 7.48 g(109.8 mmol)代替2P4MHZ以外,與合成 參考例1同樣地獲得HIPA : Im為1 : 1之包接化合物。 [合成比較例1](1 : 1與1 : 2包接化合物之混合物之製作) 向燒瓶中投入HIPA 36.43 g(200 mmol)、2P4MHZ 37.65 g(200 mmol)及曱醇230 ml,進行授拌,並加熱回流3小 時。其後,於室溫下放置一晚後,進行過濾、真空乾燥, 藉此獲得生成物64.41 g(產率87.2%)。藉由1HNMR、X線繞 射及熱分析(DSC)分析所獲得之生成物,結果該生成物顯 示出與實施例1及2不同之資料,因而判斷其係HIPA : 2P4MHZ為1 : 1之包接化合物與1 : 2之包接化合物混合而 成之結晶。又,1 : 2包接化合物之純度為18%。將所獲得 之包接化合物之溫度變化之熱分析(DSC)圖表示於圖6。 2環氧樹脂組合物之製造 153278.doc -34- ⑧ 201139358 2-1聯苯型環氧樹脂組合物之製造 [組合物參考例1] 將以咪唑換算為0.249 g之合成參考例】之方法中所獲得 之包接化合物、作為聯本型環氧樹脂之YX4〇〇〇h(三菱化 學股份有限公司製造)12.445 g、作為脫模劑之to wax(註 冊商標)131(東亞化成股份有限公司製造)〇 249 g、作為填 料之FB-940球形二氧化矽(電氣化學工業股份有限公司製 造)179.97 g、作為矽烷偶合劑之LS294〇(信越化學工業股 份有限公司製造)0.383 g、作為硬化劑之酚醛清漆笨酚 PSM-426! OH當量103(群榮化學工業股份有限公司製 造)6.701 g於l〇〇°C下加熱混練5分鐘’冷卻後進行粉碎而 製造聯苯型環氧樹脂組合物。 [組合物實施例1 ] 除使用合成實施例i之方法中所獲得之包接化合物代替 合成參考例1之方法中所獲得之包接化合物以外,與組合 物參考例1同樣地製造聯苯型環氧樹脂組合物。 2-2鄰甲紛紛搭清漆型環氧樹脂組合物之製造 [組合物參考例2 ] 將以咪嗤換算為0.378 g之合成參考例k方法中所獲得 之匕接化口物、作為鄰甲酚酚醛清漆環氧樹脂之⑽⑶· 55衣氧基§置191〜2〇1(日本化藥股份有限公司製 造)18.886 g、作為脫模劑之TOWAX(註冊商標)13U東亞化 成股份有限公司製造)G.378 g、作為填料之FB-940球形二 氧夕(電氣化學工業股份有限公司製造)169 97 g、作為 153278.doc •35- 201139358 矽烷偶合劑之LS-2940(信越化學公司製造)0 944 g、作為 硬化劑之酚醛清漆苯酚PSM_4261 OH當量1〇3(群榮化學工 業股份有限公司製造)9.443 g於loot下加熱混練5分鐘, 冷卻後進行粉碎而製造聯苯型環氧樹脂組合物。 [組合物實施例2] 除使用合成實施例1之方法中所獲得之包接化合物代替 合成參考例1之方法中所獲得之包接化合物以外,與組合 物參考例2同樣地製造鄰甲酚酚醛清漆型環氧樹脂組合 物。 2-3液狀環氧樹脂組合物之製造 [組合物參考例3] 將以咪唑換算為0·4 g之合成參考例1之方法中所獲得之 包接化合物、作為液狀環氧樹脂之Epotohto YD-128(東都 化成股份有限公司製造)10 g混合’而製造液狀環氧樹脂組 合物。 [組合物實施例3] 除使用合成實施例1之方法中所獲得之包接化合物代替 合成參考例1之方法中所獲得之包接化合物以外,與組合 物參考例3同樣地製造液狀環氧樹脂組合物。 [組合物實施例4] 除使用合成實施例4之方法中所獲得之包接化合物代替 合成參考例1之方法中所獲得之包接化合物以外,與組合 物參考例3同樣地製造液狀環氧樹脂組合物。 [組合物參考例4] 153278.doc -36- ⑧ 201139358 除使用合成參考例2之方法中所獲得之包接化合物代替 合成參考例1之方法中所獲得之包接化合物以外,與組合 物參考例3同樣地製造液狀環氧樹脂組合物。 [試驗例1] (螺旋流動試驗) 將組合物實施例1及2、組合物參考例丨及2之方法中所獲 得之環氧樹脂組合物分別壓錠,而成型為錠劑。使用阿基 米德螺旋模具與轉注成形機’將該等錠劑於17代、壓二 7〇 KgfW之條件下射出成形3分鐘,測定所製成者之長 度。螺旋㈣值係収初期值及25。口經…天後之值, 將該等值示於第1表。 於螺旋流動試驗中,此值越大表示流動性良好。 [試驗例2] (凝膠化時間) ^ ^ ^ &初霄施例3及4 '組合4 、、戶斤獲得之環氧樹脂組合物置於175t之索 失而自屬㈣刀進1定與試料之黏著性消 第:表熱板脫洛之時間或黏著性消失之時間。將結果j 凝膠化時間係於—定穩定 動性為止之時間,硬化特性 熱密封材料時,至失去 表示越快凝固,田&上^ °、選擇凝膠化時間越短 下加 流 佳為凝膠化時間短 (保存穩定性) 而尤其於為液狀環氧樹脂 之情形時,較 J5327S.doc •37· 201139358 將組合物實施例3及4、組合物參考例3之方法中所獲得 之環氧樹脂組合物於30°C下保存,並目測觀察,於發生固 化之時刻結束測定,對保存穩定性進行評價。將結果示於 第2表。 [表1] 第1表 環氧樹脂組合物 螺旋流動 初期值(cm) 25°〇7 天後(cm) 組合物參考例1 117.05 105.67 組合物實施例1 192.18 130.08 組合物參考例2 164.13 145.22 組合物實施例2 174.65 161.68 [表2] 第2表 環氧樹脂組合物 凝膠化時間(秒) 保存穩定性 組合物參考例3 226 於58〜89天之間固化 組合物參考例4 57 於21〜25天之間固化 組合物實施例3 204 100天以上未固化 組合物實施例4 44 於15〜21天之間固化 產業上之可利用性 根據本發明,可以高純度獲得芳香族羧酸化合物與咪唑 化合物之1 '· 2包接化合物。 又,於本發明中,由於成功地以高純度製造出1 : 2包接 化合物,故而變得可製造含有1 : 1包接化合物與1 : 2包接 化合物之任一者作為硬化劑或硬化促進劑的硬化性環氧樹 脂組合物及其硬化物。 【圖式簡單說明】 圖1係表示合成實施例1中所獲得之包接化合物之溫度變 化之熱分析(DSC)圖表的圖。 153278.doc -38 - ⑧ 201139358 圖2-1係表示合成實施例2中所獲得之包接化合物之溫度 變化之熱分析(DSC)圖表的圖。 圖2-2係表示合成實施例2中所獲得之包接化合物之1H-NMR圖表的圖。 圖3-1係表示合成實施例3中所獲得之包接化合物之溫度 • 變化之熱分析(DSC)圖表的圖。 圖3-2係表示合成實施例3中所獲得之包接化合物之1H-NMR圖表的圖。 圖4-1係表示合成實施例4中所獲得之包接化合物之溫度 變化之熱分析(DSC)圖表的圖。 圖4-2係表示合成實施例4中所獲得之包接化合物之1H-NMR圖表的圖。 圖5係表示合成參考例1中所獲得之包接化合物之溫度變 化之熱分析(DSC)圖表的圖。 圖6係表示合成比較例1中所獲得之包接化合物之溫度變 化之熱分析(DSC)圖表的圖。 153278.doc -39-Wherein 'R_2 represents a hydrogen atom, a Cl~C10 alkyl group or a cyanoethyl group, preferably a hydrogen atom. The aryl group or the arylalkyl group may be a C1 to C10 alkyl group, preferably a C1 to C6 alkyl group, and f 1 may have a substituent. Specific examples of the C1 to C10 alkyl group include methyl group, hexyl group, n-propyl group, isopropyl group, n-butyl group, second butyl group, isobutyl group, dibutyl butyl group, n-pentyl group, n-hexyl group and fluorene. Base, isoindolyl, thiol and the like. An aryl group means a monocyclic or polycyclic aryl group. Here, in the case of a polycyclic aryl group, in addition to the completely unsaturated group, #includes a partially saturated group. For example, a phenyl group, a decyl group, a fluorenyl group, a benzyl group, a bis group, a tetrazinc group or the like can be given. In the #, a C6 to C10 aryl group is preferred. Further, the aryl group may have a substituent. The arylalkyl group is a group in which the above aryl group is bonded to an alkyl group, and is exemplified by benzyl 153278. Doc 201139358, phenethyl, 3-phenyl-n-propyl, fluorenyl-phenyl-n-hexyl, naphthylmethylnaphthylethyl, naphthalen-2-yl-n-propyl, 茚_1_yl fluorenyl and the like. Among these, a C6 to C10 aryl C1 to C6 alkyl group is preferred. Further, the arylalkyl group may have a substituent. R3 to R5 each independently represent a hydrogen atom, a nitro group, a halogen atom, a CN20 alkyl group, a C1 to C20 alkyl group substituted by a hydroxyl group, an aryl group, an arylalkyl group or a fluorenyl group of C1 to C20. Examples of the C1 to C20 alkyl group include a methyl group, an ethyl group, a n-propyl isopropyl group, a n-butyl group, a second butyl group, an isobutyl group, a t-butyl group, a n-pentyl group, an n-hexyl group, and a decyl group. The hydrazine, isodecyl, fluorenyl, lauryl, +tridecyl, myristyl, pentadecyl, palmitoyl, heptadecyl, stearyl or the like is preferably a C1 to C10 alkyl group. Examples of the aryl group and the arylalkyl group include the same groups as the base of the ruler 2. The CK20 brewing group refers to a group in which a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or a heteroaryl group is bonded to a carbonyl group. Examples of the sulfhydryl group include a fluorenyl group; an acetamyl group, a propyl fluorenyl group, a butyl fluorenyl group, a pentyl group, a hexyl group, a heptyl group, a octyl group, an anthracenyl group, a fluorenyl group, and a thiol group. ,8-fluorenyl aryl, 3-ethyloctyl, 3,7-dimethyloctyl, deca-decyl, dodecylfluorenyl, tridecyldecyl, tetradecanedecyl, ten Five-burning base, fifteen-burning sulfhydryl, L-methylpentadecyl (tetra)yl, 14-methylpentadecanoyl, 13,13-didecyltetradecanedecyl, heptadecane, 15_ An alkylcarbonyl group such as methylhexadecane, octadecane, i-methylheptadecane, nonadecane, eicosyl and eicosyl; propylene fluorenyl , methyl propyl sulphate, allylic fluorenyl, cinnabar thiol (four) base silk; B quick base 153278. Doc -19- 201139358 alkynylcarbonyl such as benzyl or propylcarbonyl; arylcarbonyl such as benzamyl, naphthylcarbonyl, biphenylyl, fluorenylcarbonyl; 2_πpyridylcarbonyl, thienyl Isoheteroarylcarbonyl and the like. Among these, a Cl~C2〇(carbonyl group-containing) fluorenyl group is preferred, and a C1~C6 fluorenyl group is particularly preferred. Specifically, 'is the microphone represented by the formula (Π). The compound can be exemplified by imidazole, 2-ethyl-4-methylimidazole, 2-mercaptoimidazole, jbenzyl-2-indoleimidazole, 2-heptadecylimidazole, 2-undecylimidazole , 2_phenyl_4_methyl_5_ hydroxydecyl imidazole '2-phenylimidazole, 2·styl _4-methylimidazole, 1-benzyl phenyl-2-phenylimidazole, 1,2-di Mercaptoimidazole, cyanoethyl 2-methylimidazole, 1-cyanoethyl-2-ethyl-4-methylimidazole, hydrazine-cyanoethyl-2-undecylimidazole, 1- Cyanoethyl-2-phenylimidazole, 2-phenyl-4,5-dihydroxydecyl imidazole, etc., preferably 2-ethyl-4-methylimidazole, 2-methylimidazole, hydrazine-benzyl Base 2·methylimidazole, 2-heptadecylimidazole, 2-undecylimidazole, 2-phenyl-7-nonyl-5-hydroxymethylimidazole, 2-phenylimidazole or 2-phenylene Base _4,5-dihydroxymethyl mouth rice. sit. The imidazoline compound represented by the formula (II) may, for example, be 2 fluorenyl 2-phenyl imi (tetra), 2 • decyl (tetra) lin, 2 hexadecane oxazoline, 2-ethyl mum. Sitting porphyrin, 2_isopropyl hydrazine. The porphyrin, the 2, the diterpene-based saliva, the 2-phenyl-4-methylsulfate, and the like are preferably 2 methylimine. Sitting on the Lin or 2_ stupid base. (Carboxylic acid compound simazole compound eve). 1 of the alpha. (Manufacturing method of the inclusion compound or the composition thereof) The inclusion ratio of the carboxylic acid compound and the acetophenone compound which is substantially 丄: 2 or the composition thereof can be obtained by the following method or the like. 153278. Doc 8 •20· 201139358 (1) Method of adding an alcohol solution of a carboxylic acid compound to a succulent compound (7) Method of adding a few acid compound to an alcohol solution of a medicinal compound The following describes the details of the method (1). An alcohol solution of a carboxylic acid compound is added to the imidazole compound while stirring is carried out as needed. The addition of the alcohol solution of the m acid compound is carried out and is usually added continuously or in divided portions for 5 to 120 minutes. ‘,,, after the addition of the alcohol solution of the carboxylic acid compound, it is allowed to stand at room temperature for 0 to 5 hours, and is heated at room temperature to 4 Torr for 5 hours or heated to reflux. The ratio of the ratio of the acid compound to the oxime compound is preferably 1 Torr to 5 hrs relative to the slow acid compound (host), and more preferably 0. 5~3. 0 mole. The alcohol solvent is exemplified by a lower alcohol such as decyl alcohol, ethanol or n-propanol, and more preferably methanol. The amount used is usually 0% by weight relative to the carboxylic acid compound. 5 to 50 times the amount. ^ The step after the heat treatment or the heat reflux treatment may be carried out, for example, by simply stopping the heating or heating the reflux treatment, preferably by heating and then leaving it at room temperature for one night. After the solid compound is precipitated, the target compound is obtained, for example, by filtration drying. The details of the method of (2) are explained below. After the imidazole compound is suspended or dissolved in an alcohol (the alcohol suspension and the alcohol solution are referred to as an alcohol solution), the carboxylic acid compound is added while stirring as necessary. The addition of the carboxylic acid compound is not particularly limited, and it is usually added continuously or in divided portions at 5 to 12 Torr. 153278. Doc -21 - 201139358 After the addition of the carboxylic acid compound, it is allowed to stand at room temperature for 0 to 5 hours at room temperature to 40 °C. (: heating under 〇~5 hours or heating under reflux for ~5 hours. As a compounding ratio of the acid-lowering compound and the imidazole compound, the imidazole compound (guest) is preferably 〇丨~ relative to the diacid compound (main body) 1 mol. 5 〇莫耳' is better for 0. 5~3. 0 mole. The alcohol solvent may, for example, be a lower alcohol such as methanol, ethanol or n-propanol, and more preferably methanol. Use $ is usually 0% by weight relative to the acid-producing compound. 5 to 50 times the amount. For reference, a method for producing an inclusion compound of HIPA and 2p4MHZ with a molar ratio of i: i is described below. (Manufacturing method of the HIPA and 2P4MHZ molar ratio i: the inclusion compound of 丄) The molar ratio of HIPA to 2P4MHZ is substantially only 丨: i. The inclusion compound can be obtained by the following method or the like. After dissolving the HIPA in the alcohol, add (4) as needed, and add 2P4MHZ. The addition of 2P4MHZ is not particularly limited and is usually carried out continuously for 5 minutes or more, preferably 5 minutes to 12 minutes. After adding 2P4MHZ, it is left to stand at room temperature for ~5 hours, and heated at room temperature ~40 ° C for ~5 hours or heated to reflux for ~5 hours. As 1 . The ratio of the preparation method of the inclusion compound to the compounding ratio is preferably 0. The relative value of the HIPA (host) is 2, and the 2P4MHZ (guest) is preferably 0. 1~5. 0 mole, more preferably 0. 5~3. 0 mole. As 1 . The alcohol solvent of the method for producing a packaged compound may, for example, be a lower alcohol such as methanol, ethanol or n-propanol, preferably methanol. The amount used is usually 153278. Doc 2 8 201139358 For HIPA it is 〇 5~5〇. The step of treating, or heating, the refluxing treatment may, for example, be carried out by simply stopping: heat or heat reflux treatment to precipitate a solid compound, preferably by heating to a temperature-night. After the solid compound is precipitated, the target compound is obtained, for example, by filtration drying.曰 (curable epoxy resin composition) The inclusion compound of the present invention or a composition thereof can be used as an epoxy resin hardener or a hardening accelerator, mixed with an epoxy resin, for example, used as a semiconductor encapsulant 0 for use as a semiconductor seal The cured epoxy resin composition such as an agent contains an epoxy resin, an inclusion compound of the present invention, and other additives as needed. As the epoxy resin, the epoxy resin may be any of various previously known polyepoxy compounds, and examples thereof include bis(4-hydroxyphenyl)propane diglycidyl ether and bis(4_hydroxy 3'5 — > Benji), propylene, monoglycidyl hydrazine, bis(4-aminobenzopyrene), ethylene diglycidyl ether, bis(4.hydroxyphenyl)methane diglycidyl ether, isophthalic diglycidyl ether, Pyrogallol triglycidyl ether, trisylbiphenyl triglycidyl ether, tetraglycidyl dibenzophenone, bis-diphenol diglycidyl ether, tetradecyl bisphenol quinone diglycidyl ether, double Cc diglycidyl ether, bisphenol hexafluoropropane diglycidyl ether, 13•bis "^2,3-epoxypropionyl)-1-trifluoromethyl-2,2,2-trifluoro Ethyl] stupid, 1,4_bis[1_(2,3-epoxypropoxy)-1-trifluoromethyl-2,2,2-trifluoromethyl] stupid, 4,4,_ An aromatic glycidyl ether compound such as bis(2,3_epoxypropoxy)octafluorobiphenyl or a phenol novolac type diepoxide; alicyclic diepoxy condensation, ring 153278. Doc •23· 201139358 Group of epoxidized adipate, alicyclic diepoxy sulphuric acid vinegar, oxidized ethoxylated cyclohexyl epoxide, etc.; diglycidyl phthalate , diglycidyl tetrahydrophthalate, diglycidyl hexahydrophthalate, dimethyl glycerol phthalate, hexafluorophthalic acid dimethylglycolic vinegar, a glycerol vinegar compound such as benzoic acid diglycidyl vinegar, cyclopentanol glycidol 6, dimer acid glycidol vinegar, diglycidyl aniline, diglycidyl toluidine, triglycidyl amide benzene, four Glycidyl group: glycidylamine compound such as aminodiphenylmethane or diglycidyl tris-aniline; diglycidylacetamidine, glycidyl glycidyloxyalkylene urea, isocyanide A heterocyclic epoxy compound such as uric acid triglycidyl ester. Further, examples of the liquid epoxy resin include polyalkylene groups such as (poly)ethylene glycol diglycidyl hydrazide, (poly)propylene glycol diglycidyl _, trimethyl methacrylate & triglycidyl ether; Ether type epoxy compound; dimer acid diglycidyl S 曰, phthalic acid diglycidyl phthalate, tetrahydrophthalic acid diglycidyl vinegar and other glycidol vinegar type epoxy compound; (meth) acrylic acid The glycidol is a monopolymer such as cilexetil glycidyl ether or a copolymer of the monomer and other soft unsaturated monomers. The term "soft unsaturated monomer" means that the glass transition temperature of the homopolymer is less than 6 〇〇c, and examples thereof include acryl 7 , propylene ( 4 ) s s, and (meth) succinate butyl 8 ( Isobutyl methacrylate, 2-ethylhexyl (meth) acrylate, lauryl methacrylate, and the like. 2) Inorganic filler The epoxy resin composition of the present invention may contain the above-mentioned inclusion compound and epoxy resin, or may contain no 153278 in addition to the inclusion compound and epoxy resin. Doc 8 •24- 201139358 Machine-filled epoxy resin composition as inorganic filler, no glass, 蕤a + η: # n艮, for example, quartz glass is obtained by flame melting.球形 等 等 所 球形 球形 、 、 、 、 球形 球形 球形 球形 球形 球形 IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT IT These may be used alone or in combination of two or more. 3) A hardener or an effect accelerator as a hardener which can be contained in the epoxy resin composition of the present invention, as long as 2 can react with the epoxy group of the epoxy resin to harden the epoxy resin. In the same manner, the curing accelerator which can be contained in the epoxy resin group of the present invention is not particularly limited as long as it is a substance which promotes the above-mentioned curing reaction. As such a curing agent or a curing accelerator, any of those conventionally used as a curing agent or a curing accelerator for an epoxy resin may be used. For example, an amine compound such as an aliphatic amine, an alicyclic type or a heterocyclic type, a scented amine, a modified amine, or the like; a oxazole compound, an imidazoline compound, and a guanamine compound; , an ester compound, a phenol compound, an alcohol compound, a thiol compound, a (4) compound, a thioether compound, a I compound, a thiourea compound, a Lewis system: a dish, a dish compound, an acid needle system A compound, a phosphonium salt compound, an active Shihe compound, an aluminum complex, or the like. Specific examples of the curing agent or the curing accelerator include compounds. 153278. Doc -25· 201139358 Examples of the aliphatic amines include ethylenediamine, u-propylenediamine, diethylenediamine, Μ_taudiol, 16 hexanediamine, diethylenetriaminetriethylenetetraminetetraethylene Amine, monopropylene diamine, dimethylaminopropylamine, diethylaminopropylamine dimethyl hydrazine, 6. Hexamethylenediamine, pentanediamine, bis(2-dimethylaminoethyl), pentadecyl-ethylenediamine, tertiary triamine, 1,4-diazabicyclo (2,2,2 ) Xin Shao (triethylenediamine), ν, ν, ν,, ν. _ tetramethyl. ΜHexane diamine, team N'N,, y tetramethyl propylene diamine, ν, ν, ν, bound tetramethylethylenediamine, hydrazine, hydrazine _ methyl hexylamine, monobutylaminopropylamine, two Methylaminoethoxyethoxyethanol, triethanolamine, dimethylaminohexanol, and the like. Examples of the cyclized and heterocyclic amines include κ " sputum, thin hesandiamine', isophor, diamine, methyl morpholine, ethyl morpholine, hydrazine, hydrazine, hydrazine -Tris(dimethylaminopropyl)hexahydrogenate, 3,9-bis(3_aminopropene) 2'4,8,1〇-tetraoxaspiro (5,5)_| _ mono-alcohol adduct, N-aminoethyl bottom well monomethylaminoethyl peptide 11 well, bis(4-aminocyclohexyl)methane, hydrazine, Ν'-dimercaptopurine well, dinitrogen Heterobicyclo[4. 5. 0] undecene _7 and the like. Examples of the aromatic amines include o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, diaminodiphenyl decane, diaminodiphenyl hydrazide, benzyl decylamine, and dimethyl Alkylbenzylamine, m-xylylenediamine, pyridine, picoline, α-mercaptobenzylmethylamine, and the like. Examples of the modified amines include epoxy compound addition polyamine, Michael addition polyamine, Mannich addition polyamine, thiourea addition polymoon, ketone-terminated polyamine, dicyandiamide, Anthracene, an organic acid hydrazine, a diamine maleimonitrile, an amine sulfimine, a boron trifluoride-piperidine complex, a boron trifluoride-monoethylamine complex, and the like. 153278. Doc -26· 201139358 Examples of the imidazole-based compound include imidazole, indole imidazole, 2-methylimidazole, 3-methylimidazole, 4-methylimidazole, 5-methylimidazole, and ethylidazole, 2-ethyl Imidazole, 3-ethylimidazole, phenethylimidazole, 5-ethylimidazole, bupropionimidazole, 2-n-propylimidazole, hydrazine-isopropylimidazole, 2-isopropylimidazole, 1-n-butyl Imidazole, 2-n-butylimidazole, hydrazine isobutylimidazole, 2-isobutylimidazole, 2-deca-alkyl-1H-imidazole, 2-peptadecyl-m-imidazole, i,2- Dimethyl oxazole, dimethylimidazole, 2,4-dimethylimidazole, 2-ethyl-4-mercaptoimidazole, · Stupid imidazole, 2·phenyl•imidazole, 4-methyl-2-phenyl-mu 2_phenyl·4·methylmeridene, i•pyrylene_2_methylΜ, ^1 1 stupid Basic taste „sit, κ-nitroethyl-2-methyl taste. Sit, 1-cyanoethyl-2-ethyl_4·nonyl imidazole, acetophenethyl 2-_undecyl Spit, i-cyanoethyl-2_stupyl oxime, 2_phenylimidyl isocyanurate adduct, 2-methylimidazole-isocyano cyanide adduct, 2·phenyl _ 4,5-di-dimethylmethyl hydrazine, 2. Stupid base|methyl_5_minus methyl w, cyanoethyl-2-phenyl·4,5·di(2, cyanoethoxy)methyl meth.圭, i•12 院基·2·Methyl m gasification, mow, phenyl, and pyridine. As the (four) compound, for example, 2 A (tetra) can be mentioned. Sitting on the Lin, 2_ phenyl ° meters, sitting on the Lin and so on. The polyamine compound obtained by the condensation of a dimer acid and a polyamine can be mentioned as a brewable amine compound. v The compound 'is, for example, a living carbonyl compound such as an acid-lowering aryl group or a thioaryl group. As a compound, an alcohol compound, a thiol compound, a mystery 153278. Doc • 27. 201139358 Compounds and thioether compounds, for example, as a phenol resin hardener, can be enumerated. An aralkyl type phenol resin such as a phenol aryl group-based resin or a naphthol aralkyl resin; a novolac type phenol resin such as a phenol novolak resin or a cresol novolac resin, or a modified resin such as epoxy group or Butylated phenol novolak type phenol resin, dicyclopentadiene modified phenol resin, p-xylene modified phenol resin, triphenol alkane type phenol resin, polyfunctional phenol resin, and the like. Further, a polyol, a polythiol, a polysulfide, 2_(dimethylaminomethylphenol), 2,4,6-tris(dimethylaminomethyl)phenol, 2,4,6_three Tris(2-ethylhexyl) hydrochloride of (dimethylaminomethyl)phenol or the like. Examples of the gland-based compound, the sulfur-based compound, and the Lewis-based compound include a butylated pulse, a butylated melamine, a butylated sulfur gland, a trifluorinated side, etc., and an organic phosphine compound and a butyl group. An alkylphosphine such as a phosphine such as a phosphine such as a phenylphosphine; a dimethylphosphine, a diphosphine or the like: a secondary phosphine such as an alkylphosphine, a diphenylphosphine or a methylethylphosphine; and a trisphosphine monoethylphosphine And a tertiary phosphine such as triphenylphosphine. The acid anhydride-based compound may, for example, be phthalic anhydride, tetra-formic anhydride, hexahydro-o-phthalic anhydride, or acetaminophen. #风耶本-甲肝,甲其酸野, 内亚Methyltetrahydrophthalene methylene-2 endomethylene tetrachaophthalic acid anhydride, cis-butanoic acid liver, anhydride,:-butene monophthalic anhydride, trimellitic anhydride, chloric anhydride, tetras-tetraene Succinic anhydride, benzophenone tetracarboxylic anhydride (trimellitic acid vinegar), glycerol (trimellitic anhydride vinegar:: slow acidity, polysebacic anhydride, etc. methylcyclohexane 153278. Doc 8 •28· 201139358 Also as an iron salt compound, and active compound _ Shao complex, = can be listed. Aryl diazonium salt, diaryl sulfonium salt, triaryl sulfonium salt, triphenyl decyl alcohol-aluminum complex, triphenyl methoxy decane aluminum complex, peroxidation , _ — w ^ two bases > 6 kiln alcohol - three (salty sulphate) I ru complex and so on. As the above-mentioned curing agent or curing accelerator, it is particularly preferable to use an amine compound "myrazine compound or a benzophenone compound. Among the benzene 1 compounds, a phenol resin curing agent is more preferably used. 4) Other Additives In the epoxy resin composition of the present invention, in addition to the above, a plasticizer, an organic solvent, a reactive diluent, an extender, a filler, a reinforcing agent, a pigment, and a flame retardant may be blended as needed. Various additives such as a chemical agent, a thickener and a release agent. As other additives, vinyl trimethoxy decane, vinyl triethoxy decane, γ-glycidoxypropyl trimethoxy decane, γ-glycidoxypropyl triethoxy decane, γ _ mercapto propylene methoxy propyl dimethoxy zeoxime, γ-methyl propylene methoxy propyl triethoxy decane, γ-aminopropyl trimethoxy decane, γ · aminopropyl three Ethoxy oxime, Ν-β-(aminoethyl)-γ-aminopropyltrimethoxy zeoxime, Ν_β_(aminoethyl)-γ-aminopropyltriethoxy decane, hydrazine _Phenyl-γ-aminopropyltrimethoxy sulphur, Ν-phenyl-γ-aminopropyltriethoxy sulphur, 丫-s-propyltrimethoxy decane, γ-sulfanyl a decane coupling agent such as propyl triethoxy decane; calcium hydrogencarbonate, light calcium carbonate, natural cerium oxide, synthetic cerium oxide, molten cerium oxide, kaolin, clay, titanium oxide, barium sulfate, zinc oxide,虱 铭 、, magnesium hydroxide, talc, mica, crushed stone, titanic acid 153278. Doc •29- 201139358 Potassium, aluminum borate, sepiolite, hard calcite, etc.; nbr, polybutadiene, chloroprene rubber, polyfluorene oxide, crosslinked NBR, crosslinked BR, acrylic, Core-shell acrylic, urethane rubber, polyester elastomer, functional NBR containing liquid, liquid polybutadiene, liquid polyester, liquid polysulfide, modified polyoxyl , an elastomer modifier such as a urethane prepolymer; hexabromocyclodecane, bis(dibromopropyl)tetrabromobisphenol A, isocyanuric acid tris(di-propyl) ester, phosphoric acid tri Tribromoneopentyl)ester, decabromodiphenyl oxide, bis(pentabromophenyl)ethane, tris(tribromophenoxy)trimium, and exoethyl bis(tetrabromoophthalene) Amine), polybromophenyl decane, brominated polystyrene, tetrabromobis-A polycarbonate, bromobenzene oxirane, poly(pentabromobenzyl acrylate), triphenyl phosphate, tridecyl phenyl phosphate, Tris(dimethylphenyl) phosphate, toluene diphenyl phosphate, diphenylene diphenyl phosphate, bismuth (2,6-xylene) phosphate, 2-ethylhexyl diphenyl phosphate, isophthalic acid Diphenol double Phenyl phosphate vinegar), Bishuang A bis (diphenyl phosphate), bisphenol a bis (diphenyl phenyl phosphate), resorcinol bis (di-2,6-diphenyl phenyl phosphate) , tris(gas ethyl) vinegar, tris(cyclopropyl) phosphate, tris(dichloropropyl) phosphate, tris(tribromopropyl) phosphate, diethyl-N,N-double (2 Hydroxyethyl)aminomercaptophosphonate, anionic oxalic acid treated aluminum hydroxide, nitrate treated aluminum hydroxide, high temperature hot water treated aluminum hydroxide, stannic acid surface treated hydration Metal compound, magnesium hydroxide surface treated with nickel compound, oxidized town surface treated with polyoxopolymer, pr〇c〇bite, multi-surface treated hydrated metal compound, cationic polymer treated hydroxide Flame retardant such as magnesium; high density polyethylene, polypropylene, polystyrene, polydecyl propylene 153278. Doc 201139358 Dilute acid brewing, polyethylene, nylon 6,6, poly_, poly_, polyphosphonium imide, polybutylene terephthalate, poly La, polycarbonate, concrete and other engineering plastics Plasticizer; n-butyl glycidol, phenyl glycidyl ether, styrene oxide, tert-butylphenyl glycidyl ether, dicyclopentane: diepoxide, phenol, cresol, third Diluents such as phenol; extenders; enhancers; colorants; thickeners; higher fatty acids, higher fatty acid vinegar, higher fatty acid calcium, etc., such as carnauba wax or polyethylene wax and other release agents. The blending amount of the additives is not particularly limited, and the blending amount can be appropriately determined within the limits of obtaining the effects of the present invention. Further, the epoxy resin composition of the present invention may contain other resins in addition to the epoxy resin. Examples of the other resin include a poly-resin resin, an acrylic resin, a fluorene-based resin, and a polyurethane resin. 5) Preparation of epoxy resin composition and cured product thereof The ratio of the epoxy resin to the inclusion compound of the present invention or a combination thereof is 'with respect to the epoxy group of the epoxy resin, 1 mole, and the compound 戍The content of the imidazole compound in the composition is preferably 〇〇ι~ι〇 molar is preferably 0·1~i. 0 mole, more preferably 0. 3~1. 0 mole. Further, the epoxy resin is formed into a combination (4) by mixing an epoxy resin with the inclusion compound of the present invention or a composition thereof, but in order to form a charge-mixed state, it is usually 60 to just. Heating at a temperature of about C is mixed. Two: In the manufacture of an epoxy hardening resin, the single liquid at the temperature at this time is stable. The epoxy resin composition produced may be either solid or liquid. And h as a curing method for the epoxy resin forming composition, as long as it is heated 153278. Doc -31 · 201139358 The method of curing the composition for forming an epoxy resin is not particularly limited, and the heating temperature for the heat treatment is usually 60 to 250 °C. EXAMPLES Hereinafter, examples will be described, but the technical scope of the present invention is not limited to the examples. Further, in the following examples, iNMR was carried out by using DMSO-d6 or MeOH-d4 as a measurement solvent and measuring at 25 °C. 1 Preparation of the inclusion compound [Synthesis Example 1] 2P4MHZ was added to the flask. 67 g (109. After 8 mmol), while stirring, add HIPA 20 g (l 09. 8 mmol) half of the liquid obtained by dissolving in 170 ml of sterol. Wash with 11 mL of methanol and place at room temperature. After 5 hours, while stirring, the remaining HIPA methanol solution was added, washed with 11 mL of methanol, and placed at room temperature for 0. After 5 hours, it was heated to reflux for 3 hours. Thereafter, after standing at room temperature for one night, it was filtered and vacuum dried to obtain a product 28. 89 g (yield 71%). The product obtained was analyzed by 1H NMR, X-ray diffraction and thermal analysis (DSC), and as a result, the product was HIPA: 2P4MHZ was a crystal of the inclusion compound of 1:2. Further, the purity of the 1:2 inclusion compound was 91%. A thermal analysis (DSC) chart of the temperature change of the obtained inclusion compound is shown in Fig. 1. [Synthesis Example 2] 2P4MHZ was added to the flask. 67 g (109. 8 mmol) and sterol 130 ml and mixed in the alcohol solution, while stirring, add HIPA 10 g in 20 minutes (54. 9 mmol). Place at room temperature 0. After 5 hours, add 153278. Doc -32· 8 201139358 Heat reflux for 3 hours. Then, after standing at room temperature for one night, it was filtered and vacuum dried, thereby obtaining a product 29. 91 g (yield 97. 5%). The product obtained was analyzed by WNMR, X-ray diffraction and thermal analysis (DSC), and as a result, the product was HIPA: 2P4MHZ was a crystal of a 1:2 inclusion compound. Further, the purity of the 1:2 inclusion compound was 97%. The thermal analysis (DSC) chart and the iNMR chart of the temperature change of the obtained inclusion compound are shown in Fig. 2-1 and Fig. 2-2. [Synthesis Example 3] 2P4MHZ was added to the flask. 67 g (109. After 8 mmol), while stirring, add HIPA 10 g in 15 minutes (54. 9 mmol) liquid obtained by dissolving in 130 ml of methanol. Place at room temperature 0. After 5 hours, the mixture was heated under reflux for 3 hours. Thereafter, after standing at room temperature for one night, it was filtered and vacuum dried to obtain a product 29. 74 g (yield 97%). The obtained product was analyzed by hNMR, X-ray diffraction and thermal analysis (DSC), and as a result, the product was HIPA: 2P4MHZ was a crystal of a 1:2 inclusion compound. Further, the purity of the 1:2 inclusion compound was 99%. The thermal analysis (DSC) chart and the ]HNMR chart of the temperature change of the obtained inclusion compound are shown in Figs. 3-1 and 3-2. [Synthesis Example 4] Except that an unsubstituted mic 0 (hereinafter referred to as Im) was used. 48 g (109. 8 mmol) In the same manner as in Synthesis Example 2 except for 2P4MHZ, an inclusion compound having HIPA: Im of 1:2 was obtained. Further, the purity of the 1:2 inclusion compound was 77%. The thermal analysis (DSC) chart and the iNMR chart of the temperature change of the obtained inclusion compound are shown in Fig. 4-1 and Fig. 4-2. 153278. Doc -33- 201139358 [Synthesis Reference Example 1] (1: Preparation of inclusion compound) HIPA 20 g was introduced into the flask (109. 8 mmol) and 126 ml of methanol were mixed and mixed to obtain 2P4MHZ in 15 minutes while stirring. 67 g (109. 8 mmol). After standing at room temperature for 2 hours, it was heated to reflux for 3 hours. Then, after standing at room temperature for one night, it was filtered and vacuum dried, thereby obtaining a product 39. 56 g (yield 97. 3%). The product obtained was analyzed by 'HNMR, X-ray diffraction and thermal analysis (DSC), and as a result, the product was HIPA: 2P4MHZ was a 1:1 crystal of the inclusion compound. Further, the purity of the 1:2 inclusion compound was 0%. A thermal analysis (DSC) chart of the temperature change of the obtained inclusion compound is shown in Fig. 5. [Synthesis Reference Example 2] Except for using lm 7. 48 g (109. In the same manner as in the synthesis of Reference Example 1, except that 2P4MHZ was used, an inclusion compound having a HIPA: Im of 1:1 was obtained. [Synthesis Comparative Example 1] (Preparation of a mixture of 1:1 and 1:2 inclusion compound) HIPA was introduced into a flask 36. 43 g (200 mmol), 2P4MHZ 37. 65 g (200 mmol) and 230 ml of sterol were mixed and heated under reflux for 3 hours. Then, after standing at room temperature for one night, it was filtered and vacuum dried, thereby obtaining a product 64. 41 g (yield 87. 2%). The obtained product was analyzed by 1H NMR, X-ray diffraction, and thermal analysis (DSC), and as a result, the product showed data different from those of Examples 1 and 2, and thus it was judged that it was HIPA: 2P4MHZ was a 1:1 package. A crystal obtained by mixing a compound with a 1:2 inclusion compound. Further, the purity of the 1:2 inclusion compound was 18%. A thermal analysis (DSC) chart of the temperature change of the obtained inclusion compound is shown in Fig. 6. 2 Manufacture of epoxy resin composition 153278. Doc -34- 8 201139358 Manufacture of 2-1 biphenyl type epoxy resin composition [Composition reference example 1] will be converted to 0 by imidazole. The inclusion compound obtained in the method of the synthesis of 249 g, YX4〇〇〇h (manufactured by Mitsubishi Chemical Corporation) as a conjugated epoxy resin. 445 g, to wax (registered trademark) 131 (manufactured by East Asia Chemical Co., Ltd.) 249 249 g as a release agent, FB-940 spherical cerium oxide (manufactured by Electric Chemical Industry Co., Ltd.) as a filler 179. 97 g, LS294 as a decane coupling agent (manufactured by Shin-Etsu Chemical Co., Ltd.) 0. 383 g, novolac phenol as a hardener PSM-426! OH equivalent 103 (manufactured by Qunrong Chemical Industry Co., Ltd.) 6. 701 g was heated and kneaded at 10 ° C for 5 minutes. After cooling, the mixture was pulverized to produce a biphenyl type epoxy resin composition. [Composition Example 1] A biphenyl type was produced in the same manner as in Reference Example 1, except that the inclusion compound obtained in the method of Synthesis Example i was used instead of the inclusion compound obtained in the method of Synthesis Reference Example 1. Epoxy resin composition. 2-2 Neighbors are made of varnish-type epoxy resin composition [Composition Reference Example 2] will be converted to 0. 378 g of the conjugated mouth obtained in the method of the reference example k, as the o-cresol novolac epoxy resin (10) (3) · 55 ethoxylate § 191~2〇1 (manufactured by Nippon Kayaku Co., Ltd.) 18. 886 g, TOWAX (registered trademark) 13U as a release agent, manufactured by East Asia Chemical Co., Ltd.) G. 378 g, FB-940 spherical dioxin (manufactured by Electric Chemical Industry Co., Ltd.) 169 97 g as a filler, as 153278. Doc •35- 201139358 LS-2940 (manufactured by Shin-Etsu Chemical Co., Ltd.) 0 944 g of decane coupling agent, novolac phenol PSM_4261 OH equivalent as a hardener 1〇3 (manufactured by Qunrong Chemical Industry Co., Ltd.) 9. 443 g was heated and kneaded under a loot for 5 minutes, cooled and then pulverized to produce a biphenyl type epoxy resin composition. [Composition Example 2] O-cresol was produced in the same manner as in Reference Example 2, except that the inclusion compound obtained in the method of Synthesis Example 1 was used instead of the inclusion compound obtained in the method of Synthesis Reference Example 1. A novolac type epoxy resin composition. Manufacture of 2-3 liquid epoxy resin composition [Composition Reference Example 3] The inclusion compound obtained in the method of Synthesis Reference Example 1 in terms of imidazole was converted to 0.4 g, as a liquid epoxy resin. Epotohto YD-128 (manufactured by Tohto Kasei Co., Ltd.) 10 g of 'mixed' to produce a liquid epoxy resin composition. [Composition Example 3] A liquid ring was produced in the same manner as in Reference Example 3, except that the inclusion compound obtained in the method of Synthesis Example 1 was used instead of the inclusion compound obtained in the method of Synthesis Reference Example 1. Oxygen resin composition. [Composition Example 4] A liquid ring was produced in the same manner as in Reference Example 3, except that the inclusion compound obtained in the method of Synthesis Example 4 was used instead of the inclusion compound obtained in the method of Synthesis Reference Example 1. Oxygen resin composition. [Composition Reference Example 4] 153278. Doc-36- 8 201139358 A liquid epoxy was produced in the same manner as in Reference Example 3, except that the inclusion compound obtained in the method of Synthesis Reference Example 2 was used instead of the inclusion compound obtained in the method of Synthesis Reference Example 1. Resin composition. [Test Example 1] (Spiral flow test) The epoxy resin compositions obtained in the compositions of Examples 1 and 2, and the methods of Reference Examples 2 and 2, respectively, were tableted and molded into tablets. These tablets were injection molded for 3 minutes under the conditions of 17 passages and a pressure of 7 〇 KgfW using an Archimedes screw mold and a transfer molding machine, and the length of the produced product was measured. The spiral (four) value is the initial value and 25. The value of the mouth is ... after the day, the equivalent value is shown in the first table. In the spiral flow test, the larger the value, the better the fluidity. [Test Example 2] (gelation time) ^ ^ ^ & preliminary application examples 3 and 4 'combination 4, the epoxy resin composition obtained by the household is placed at 175t and the self-owned (four) knife is set The adhesion to the sample is eliminated: the time when the hot plate is removed or the time when the adhesion disappears. When the gelation time of the result j is set to the time of stable stability, when the heat-sealing material is hard-sealed, the faster the solidification is reached, the faster the solidification is, the lower the gelation time is, and the shorter the gelation time is. For the gelation time is short (storage stability) and especially for the case of liquid epoxy resin, compared to J5327S. Doc •37· 201139358 The epoxy resin compositions obtained in the methods of the compositions of Examples 3 and 4 and the composition of Reference Example 3 were stored at 30 ° C and visually observed, and the measurement was terminated at the time of curing, Storage stability was evaluated. The results are shown in the second table. [Table 1] Table 1 Epoxy Resin Composition Spiral Flow Initial Value (cm) 25° 〇 7 days later (cm) Composition Reference Example 1 117. 05 105. 67 Composition Example 1 192. 18 130. 08 Composition Reference Example 2 164. 13 145. 22 Composition Example 2 174. 65 161. 68 [Table 2] Table 2 Epoxy Resin Composition Gelation Time (sec) Preservation Stability Composition Reference Example 3 226 Curing Composition between 58 and 89 Days Reference Example 4 57 Between 21 and 25 days Cured Composition Example 3 204 100-day or more uncured composition Example 4 44 Curing industrial property between 15 and 21 days According to the present invention, an aromatic carboxylic acid compound and an imidazole compound can be obtained in high purity. '· 2 packaged compound. Further, in the present invention, since the 1:2 inclusion compound is successfully produced in high purity, it is possible to manufacture either a 1:1 inclusion compound and a 1:2 inclusion compound as a hardener or hardening. A curable epoxy resin composition of a promoter and a cured product thereof. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a view showing a thermal analysis (DSC) chart of temperature change of the inclusion compound obtained in Synthesis Example 1. 153278. Doc-38 - 8 201139358 Fig. 2-1 is a diagram showing a thermal analysis (DSC) chart of the temperature change of the inclusion compound obtained in Synthesis Example 2. 2-2 is a view showing a 1H-NMR chart of the inclusion compound obtained in Synthesis Example 2. Figure 3-1 is a graph showing the temperature of the inclusion compound obtained in Synthesis Example 3, and the thermal analysis (DSC) chart of the change. Fig. 3-2 is a view showing a 1H-NMR chart of the inclusion compound obtained in Synthesis Example 3. Fig. 4-1 is a graph showing a thermal analysis (DSC) chart of the temperature change of the inclusion compound obtained in Synthesis Example 4. 4-2 is a view showing a 1H-NMR chart of the inclusion compound obtained in Synthesis Example 4. Fig. 5 is a graph showing a thermal analysis (DSC) chart for synthesizing the temperature change of the inclusion compound obtained in Reference Example 1. Fig. 6 is a view showing a thermal analysis (DSC) chart for synthesizing the temperature change of the inclusion compound obtained in Comparative Example 1. 153278. Doc -39-
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010010375 | 2010-01-20 | ||
JP2010228645 | 2010-10-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201139358A true TW201139358A (en) | 2011-11-16 |
TWI525073B TWI525073B (en) | 2016-03-11 |
Family
ID=44306676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100101845A TWI525073B (en) | 2010-01-20 | 2011-01-18 | Encapsulating compound and method for producing the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5536108B2 (en) |
CN (1) | CN102725273B (en) |
BR (1) | BR112012016151A2 (en) |
TW (1) | TWI525073B (en) |
WO (1) | WO2011089874A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012035755A1 (en) * | 2010-09-15 | 2012-03-22 | 日本曹達株式会社 | Liquid curable epoxy resin composition and adhesive agent containing same |
JP6046894B2 (en) * | 2011-12-28 | 2016-12-21 | ナミックス株式会社 | Liquid encapsulant |
JP5901349B2 (en) * | 2012-02-28 | 2016-04-06 | 古河電気工業株式会社 | Adhesive film, tape for wafer processing, and method for producing adhesive film |
US10266642B2 (en) * | 2014-09-08 | 2019-04-23 | Nippon Soda Co., Ltd. | Crystal polymorphism of inclusion compound and method for producing same, and curable resin composition |
CN106589828A (en) * | 2016-12-22 | 2017-04-26 | 科化新材料泰州有限公司 | Environment-friendly epoxy resin composition and preparation method thereof |
GB2576875B (en) | 2018-08-30 | 2022-08-31 | Hexcel Composites Ltd | Improvements in or relating to curing agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5000036B2 (en) * | 2000-12-11 | 2012-08-15 | 日本曹達株式会社 | Method for producing molecular compound |
JP5475940B2 (en) * | 2006-01-20 | 2014-04-16 | 日本曹達株式会社 | Production method of clathrate compound by slurry method |
KR101176809B1 (en) * | 2006-12-21 | 2012-08-24 | 닛뽕소다 가부시키가이샤 | Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
CN101802049B (en) * | 2007-09-21 | 2012-09-12 | 日本曹达株式会社 | Inclusion complex containing epoxy resin composition for semiconductor encapsulation |
-
2011
- 2011-01-14 BR BR112012016151A patent/BR112012016151A2/en not_active Application Discontinuation
- 2011-01-14 WO PCT/JP2011/000172 patent/WO2011089874A1/en active Application Filing
- 2011-01-14 CN CN201180006305.8A patent/CN102725273B/en not_active Expired - Fee Related
- 2011-01-14 JP JP2011550838A patent/JP5536108B2/en not_active Expired - Fee Related
- 2011-01-18 TW TW100101845A patent/TWI525073B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2011089874A1 (en) | 2011-07-28 |
CN102725273A (en) | 2012-10-10 |
JPWO2011089874A1 (en) | 2013-05-23 |
TWI525073B (en) | 2016-03-11 |
JP5536108B2 (en) | 2014-07-02 |
BR112012016151A2 (en) | 2015-09-15 |
CN102725273B (en) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI473831B (en) | Liquid hardened epoxy resin composition and a binder containing the same | |
TWI482794B (en) | A crystallizer, a hardening agent, a hardening accelerator, an epoxy resin composition, and an epoxy resin composition for semiconductor sealing | |
JP5243441B2 (en) | Epoxy resin composition for semiconductor encapsulation containing inclusion complex | |
TWI491635B (en) | Epoxy-hardening resin forming composition and hardened product thereof | |
JP6461170B2 (en) | Thermosetting resin composition | |
TW201139358A (en) | Clathrate and method for producing same | |
TW201037007A (en) | Epoxy resin composition, curing agent, and curing accelerator | |
TW200914485A (en) | One liquid type cyanate-epoxy composite resin composition | |
TW201835146A (en) | Inclusion compound, method for manufacturing the same and use thereof | |
JP2010180337A (en) | Epoxy resin composition for sealing semiconductor | |
TW200909467A (en) | Liquid epoxy resin, epoxy resin composition, and cured product | |
US20160017088A1 (en) | Novel inclusion compound | |
JP2013170173A (en) | Adhesive for sus substrate | |
JP2012025670A (en) | Isocyanurate compound | |
JP2015042736A (en) | Latent curing catalyst, thermosetting resin composition, and resin-sealed semiconductor device | |
JP5546914B2 (en) | Novel inclusion complex, epoxy resin composition and epoxy resin composition for semiconductor encapsulation | |
JP5595047B2 (en) | Inclusion compound, curing agent or curing accelerator for epoxy resin containing the same, and epoxy resin composition | |
TW201002753A (en) | Inclusion complex containing epoxy resin composition for semiconductor encapsulation | |
TWI802196B (en) | Resin composition and resin film | |
JP6251407B2 (en) | Inclusion compound crystals, method for producing the same, and curable resin composition | |
JP2015199904A (en) | Curing agent for thermosetting resin, thermosetting resin composition using the same and photo-semiconductor device using the thermosetting resin composition as encapsulating material or reflector | |
TW202346468A (en) | Epoxy resin composition and cured product thereof | |
JP2016141806A (en) | Polycarboxylic acid resin, thermosetting resin composition using the same and optical semiconductor device using the thermosetting resin composition as encapsulation material or reflector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |